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1. INTRODUCTION 
 
“ச ொல்னிடவ஬ வ஡஬ிக்குச்  ஡ொ ி஬ன்நொன் 
 ச ொல்னவ஬ வ஡஬ியும் ஢ந்஡ிக்கு ச ொல்ன 
஢ல்னிடவ஬ ஢ந்஡ி஡ன் ஬ந்஡ிரிக்கு ச ொல்ன 
 ஢஦முடன் ஡ன்஬ந்஡ிரி ஦சு஬ிணிக்குச் ச ொல்ன 
அல்னிடவ஬ ஦சு஬ிணி஦ொத் வ஡஬ர் ஡ொமும் 
 அக்த்஡ி஦ர்க் குர஧த்஡ிடவ஬ ஦ம்மு ணநீ்஡ி஧ன் 
புல்னிடவ஬ புனத்஡ி஦ர்க் குதவ஡  ிக்க 
 புனத்஡ி஦ய௃ம் வ஡ர஧஦ர்க்குப் புகன்நிட்டொவ஧” 
- யூகி ர஬த்஡ி஦  ிந்஡ொ஥஠ி 8001 
 
  Siddha system of medicine is the most ancient medical science which is 
propounded and practiced by eminent spiritual scientists called Siddhars. Siddhars are 
those who lived and maintaining their bodies as they desire best. Siddhars know the 
importance of a healthy body. They were ever young and healthy.They analysed the 
importance drugs for a strong physique and had wonderful medicine with them to 
keep the body imperishable. Thus they attained the eight Siddhis. (Attama Siddhi).  
 
Both an ascetic and a common man are used to take care of his health was said 
by the Siddhar Thirumoolar: 
     “உடம்தொர் அ஫ி஦ின் உ஦ி஧ொர் அ஫ி஬ர் 
   ஡ிடம்தட ச஥ய்ஞொணம் வ ஧வும் ஥ொட்டொர் 
   உடம்ரத ஬பர்க்கும் உதொ஦ம் அநிந்வ஡ன் 
   உடம்ரத ஬பர்த்வ஡ன் உ஦ிர் ஬பர்த்வ஡வண” 
- ஡ிய௃஥ந்஡ி஧ம்2 
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In Siddha system of medicine, there is a close relationship between man and 
universe (Prabancham). Whatever changes occur in the prabancham, influences the 
human body also. It has been illustrated as, 
     “அண்டத்஡ில் உள்பவ஡ திண்டம் 
திண்டத்஡ில் உள்பவ஡ அண்டம் 
அண்டமும் திண்டமும் ஒன்வந 
அநிந்து஡ொன் தொர்க்கும் வதொவ஡” 
-  ட்டமுணி ஞொணம்3 
Siddha system of medicine practiced in South India has number of remedies 
for various ailments as mentioned in Siddha pharmacopoeia which include drugs of  
 
 Mooligai (Herbal) 
 Thathu (Inorganic substances) 
 Jeevam (Animal products) 
 
According to their mode application the Siddha medicine could be categorized 
into two classes: 
1. Internal medicine  
2. External medicine 
 
Among 32 internal  medicine mezhugu is one among them and its shelf life is 
for 5 years. 
 
Mezhugu :  
This is two types: 
a) Araippu mezhugu (obtained by grinding drugs ) 
b) Churrukku mezhugu (obtained by heating them by adding oily 
substances)
4
. 
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Toxicology is a science of poisons which includes detection and knowledge 
about the nature and effects of poisons as well as treatment of poisoning
5
. The goal of 
toxicity assessment is to identify adverse effects of a substance. The relationship 
between dose and its effects on the exposed organism is of high significance in 
toxicology. Siddhars are well known about the toxic effect of drugs and their specific 
antidotes. In Siddha system there are so many medicines which are used for various 
diseases. Some medicines are prepared using metallic and mineral compounds after 
their purification. 
Nowadays there is a need to evaluate the toxicity of such drug formulations. 
One of the formulations   Rathi nagara rasa mezhugu mentioned in anuboga 
vaidhaya naveneetham
6
. The ingredients of Rathi nagara rasa mezhugu are metallic 
and herbal compounds like Rasam (Mercury), Ganthagam (Sulphur), Serankottai 
(semecarpus anacardium) cures the disease of Lingaputtru (Penial cancer), 
Algulputtru (Cervix cancer), Araiyaappu (Adenitis), Kandamaalai (Cervical adenitis), 
Karunkuttam, Senkuttam (Leprosy), Megaranam (Syphilis), Kaalkai mudakku 
(Rheumatoid Arthritis). 
So far there is no scientific rationale carried out for its toxicity profile, hence I 
proposed to take Rathi nagara rasa mezhugu for my dissertation study to evaluate the 
toxicity profile in animal models.  
Thus this study will help in further extension of the therapeutic potential of 
Rathi nagara rasa mezhugu (RNM). 
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                                       2. AIM AND OBJECTIVES 
 
AIM 
To evaluate the Preclinical safety profile of Rathi nagara rasa mezhugu 
(RNM) – a herbo-mineral preparation. 
 
OBJECTIVES 
1. To analytical evaluation of Rathi nagara rasa mezhugu  
2. To study the toxicity profile of Rathi nagara rasa mezhugu . 
 
SECONDARY OBJECTIVES 
1. Literature of review 
2. Preparation of Rathi nagara rasa mezhugu . 
3. To do the following studies on Rathi nagara rasa mezhugu  
 Physico-chemical analysis and Phyto- chemical analysis 
 Biochemical analysis 
 Heavy metal analysis by using ICP-OES 
 Particle size analysis by using SEM 
 Acute Oral Toxicity study as per OECD guideline-423 
 Repeated 28-days Oral Toxicity study as per OECD guideline-407 
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                                                இ஧சம் 
வ஬று பத஦ர்கள்: 
஡சாங்க ஢ிகண்டில் கூநி஦வ஬: 
 கா஧ம், சூ஡ம், புண்஠ி஦ம், கற்தம், சா஥ம், சத்து, சூரி஦஬ிவ஧ா஡ி, சா஡ி, 
சூத்஡ி஧ன், துள்பி, ஈசன், ஬ரீி஦ம், சூழ்ச்சி, ஢ீர், ஬ிண்஠ிணரீ், ஬ிண்஥ருந்து, இ஧஡ம், 
சுக்கினம், வதாகம், ப௄னம், சிந்தூ஧ம், சிந்து, தக்கி஧ம், த஡ிபணண்தந்஡ி, தா஧஡ம், 
கணல், பூ஡ம். 
 
சட்டப௃ணி ஢ிகண்டில் கூநி஦வ஬: 
 இணிவ஥, சி஬சக்஡ி, ஬ரு஠த்வ஡ான், ஡ணிவ஥, சங்க஧ன்஬ிந்து, தணிவ஥, 
த஧ாத஧ம், தாய்ந்஡ிடுதூ஥ம், கணிவ஥, ச஧க்கிற்கனந்஡ிடுசீ஬ன், சி஬ன்஬ிந்து, 
கா஬ன், சி஡நிக்காண்வதான், வகசரி, வ஬ந்஡ன், தா஬ன், அந்஡஧கந்஡ன், ஆ஡ி, 
஬஧ாட்டி஦ன், சுந்஡஧ம், பசாற்குநி, தூ஥ம், ஥கா஥஧ம், ஥ந்஡஧ம், ஥ஞ்சி, ஥ாரு஡ம், 
஥கிதன், ஬ிந்஡஧ம், சிவன, க஠஬ன், ஥வனக்குந஬ன், ஬ாசுகி஢ா஡ன், கந்஡ன், 
கா஬க்குடிவ஦ான். 
 
இ஧சத்஡ின் திரிவுகள்: 
1. இ஧சம் 
2. இ஧வசந்஡ி஧ன் 
3. சூ஡ம் 
4. ஥ிச஧கம் 
5. தா஧஡ம் 
 
சுவ஬: 
 அறுசுவ஬, சிநப்தாய் இணிப்பு. 
 
஬ரீி஦ம்: 
 ப஬ப்த சீ஡ ஬ரீி஦ங்கள் இ஧ண்டும் பகாண்டது. 
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திரிவு: 
 ஋ப்பதாருவப இ஡ற்குத் துவ஠஥ருந்஡ாக்கிக் பகாடுக்கின்வநாவ஥ா 
அப்பதாருபின் திரிவ஬ இது அவடப௅ம். 
 
பசய்வக: 
 உடல்வ஡ற்நி 
 உடல்உ஧஥ாக்கி 
 ஥னம்வதாக்கி 
 தித்஡஢ீ஧கற்நி 
 ஬கீ்கப௃றுக்கி 
 உ஥ிழ்஢ீர்பதருக்கி 
 சிறு஢ீர்பதருக்கி 
 வ஥க஢ாசிணி 
 
஥கிவ஥ 
           இது சீ஡த்஡ால் உண்டாகும் வ஢ாய்கட்கன்நி ப஬ப்தத்஡ால் 
உண்டாகும் தி஠ிகட்கும், உள்பாட்சிக்கன்நி ப஬பி஦ாட்சிக்கும் 
஋ல்னா஬ற்நிற்கும் ஡வனசிநந்஡து. இ஧சம் ப௃ங்கூநப்தட்டது வதான்று ப஬ப்தம் 
அல்னது சீ஡ ஬ரீி஦ங்கவப ஥ட்டுப௃வட஦ ஥ற்ந பதாருள்கவப வதானன்நி 
ப஬ப்த சீ஡ ஬ரீி஦ங்கவப ச஥ அப஬ிலுவட஦து. ஆவக஦ால் 
஋஬ரீி஦த்வ஡ப௅ப௃வட஦ பதாருள்கவபாடு வசர்கின்நவ஡ா அ஡ன்  ஬ரீி஦த்வ஡ப௅ம் 
பசய்வகப௅ம் அவடப௅ம் ஡ன்வ஥஬ாய்ந்த்஡து. 
 
தா஡஧சத்஡ின் பதாதுகு஠ம்: 
“஬ி஫ிவ஢ாய் கி஧ந்஡ிகுன்஥ம் ப஥ய்ச்சூவன புண்குட் 
ட஫ிகானில் ஬ிந்து஬ிணால் அத்வ஡ – ஬஫ி஦ாய் 
புரிப௅ ஬ி஡ி ஦ாது புரி஦ிவணா ப஦ல்னாம் 
இரிப௅஬ி஡ி ஦ாது ஥ில்வன” 
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பதாருள்: 
 சி஬ ஬ரீி஦ம் ஋ங்கின்ந இ஧சத்வ஡ ப௃வநப்தடி ஥ருந்஡ாக்கிக் பகாடுக்க 
அது கண்வ஠ாய், கி஧ந்஡ி, ஋ண்஬வககுன்஥ம், சூவன, பதரும்புண், ப஡ாழுவ஢ாய், 
஬பிக்குவநவு ப௃஡னி஦ வ஢ாய்கவப ஢ீக்கும். 
 
஢ற் கு஠ம்: 
 குரு஡ிவ஦ச் சுத்஡ி பசய்து துர்஢ீவ஧ ஢ீக்கல் 
 குரு஡ிவ஦ப௅ம் சுக்கினத்வ஡ப௅ம் பதருக்கல் 
 தசிவ஦த் தூண்டல் 
 கிரு஥ிகவபக் பகான்று புண்புவ஧கவப ஆற்நல் 
 உடல்ப௃ழு஬வ஡வ஦ா அல்னது உள்ளும் புநப௃஥ான் உறுப்தின் 
தகு஡ிவ஦வ஦ா உறுப்தின் ப௃ழு஬வ஡வ஦ா தற்நி஦ ஬ி஦ா஡ிகவப 
கு஠஥ாக்கல் 
 ப௃க ஬சீக஧த்வ஡ உண்டாக்கல் 
 ஥ந஡ிவ஦ எ஫ித்து ப௄வபக்கு க஬ண சக்஡ிவ஦த் ஡஧ல் 
 ஢஧ம்புக் கூட்டங்கவப ஬ன்வ஥ப௅நச் பசய்஡ல் 
 ஥ணவ஡ எரு ஢ிவன஦ில் ஢ிறுத்஡ி ஞாணத்வ஡ ஬ிருத்஡ி பசய்த்ல் 
 ப௄ப்வத எ஫ித்து ஆப௅வப ஬பர்த்஡ல் 
 
஡ீக் கு஠ம்: 
இ஧சத்வ஡ சரி஦ாண ப௃வந஦ில் ப௃டித்து உண்஠ாத்஡ால் ஬ரும் 
குற்நங்கள்  அவ஢கம். 
 
இ஧ச வ஡ாடம்: 
 இ஧ச வ஡ாடம் 2 ஬வக 
1. 8 ஬வக வ஡ாடம் 
2. 7 ஬வகசட்வட 
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இ஧ச சுத்஡ி ப௃வநகள்: 
எரு தனம் இ஧சத்஡ிற்கு தும்வத சப௄னச்சாறு (4¾தனம்) ஬ிட்டு சூரி஦புடம் 
வ஬க்கவும். இவ்஬ாவந 10 ஢ாட்களுக்கு ஢ாள்வ஡ாறும் பு஡ி஦ சாறு ஬ிட்டு 
ப஬ய்஦ினில் வ஬க்கவும். திநகு சாறு ஬ிடா஥ல் ப௃ற்நிலும் சு஬றும்தடி 
ப஬ய்஦ினில் வ஬த்ப஡டுக்கவும். இம்ப௃வநவ஦ வ஥லும் எரு ப௃வந 
பசய்஦வும். இவ்஬ி஧சத்வ஡ப௅ம் இ஧சத்துடன் உள்ப தூவபப௅ம் எரு 
஥ட்தாண்டத்஡ினிட்டு 2தடி தும்வதச்சாறு ஬ிட்டு க஬சம் பசய்து பூ஥ி஦ில் 20஢ாள் 
புவ஡த்து ஋டுக்கவும் .திநகு ஢ீர் ஬ிட்டு கழு஬ி ஋டுக்கவும். இவ்஬ாறு சுத்஡ி பசய்஡ 
இ஧சம், தற்தம், பசந்தூ஧ம், குரு, குபிவக ப௃஡னி஦஬ற்நிற்கு ஆகும். 
 
எரு தனம் இ஧சத்வ஡ பசங்கல் ஥ாத்தூபிலும் ஥ஞ்சள்பதாடி஦ிலும் 
எவ்ப஬ாரு ஥஠ிவ஢஧ப௃ம் ஆட்டி சுத்஡஢ீரில் அனம்தி, எரு தடி வ஥ணிச் 
சாற்நினிட்டு அடுப்வதற்நி சாறு சுண்டும் தடி ஋ரித்து ஋டுக்வக஦ில் சுத்஡ி஦ாகும். 
  
5தனம் இ஧சத்஡ிற்கு 1தனம் சித்஡ி஧ப௄ன வ஬ர்ப்தட்வடத் தூள் 1தனம் 
஡ிரிகடுகு பதாடி, 1தனம் கா஦ம், 1தனம் இந்துப்புத்தூள் , இத் தூள்கவப சிநிது 
சிநி஡ாய் வசர்த்துக் கல்஬த்஡ினிட்டு 36஥஠ி வ஢஧ம் அவ஧த்து ஋டுக்க தின்பு 1கு஫ல் 
பகாண்டு தூள்கவப ஊ஡ி஢ீக்குக். இவ்஬ி஡ம் 7 ப௃வந பசய்஦ இ஧சம் உ஦ர்஡஧ 
சுத்஡ி஦ாகும். 
  
வ஬ண்டி஦ அபவு இ஧சத்வ஡ தூ஦பகட்டித் து஠ி஦ினிட்டு 1000ப௃வந 
தி஫ிந்ப஡டுக்கவும். இவ஡ எரு ஥ட்சட்டி஦ினிட்டு அ஡ன் ஥ீது எரு 
அங்குன஥ிருக்கும் தடி சுத்஡ ஢ீர் ஬ிட்டு சிறு஡ீ஦ில் ஋ரிக்கவும். ஢ீர் குவந஦ா஥ல் 
அந்஡ அபவ஬காத்துக் பகாள்பவும். ஢ீர் கரு஢ிநம் அவடந்஡வுடன் ஋டுத்஡஢ீவ஧ 
காடி஢ீரில் ஢ான்கு அல்னது ஍ந்து ப௃வந கழு஬ி ஋டுக்கபூ஧஠ சுத்஡ி஦ாகும். 
  
஬ிவ஡ ஢ீக்கிண ஥ிபகா஦ில் இ஧சத்வ஡ ஬ிட்டு வகாவ஬஦ிவனவ஦ 
அவ஧த்து 4஬ி஧ற்கவட கன்ம் க஬சித்து சீவன஥ண் 7 பசய்து குக்கிடப்புட ஥ிட்டு 
஋டுக்வக஦ில் சுத்஡ி஦ாகும். 
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தத்஡ி஦ம்: 
 இ஧ச சம்தந்஡஥ாண ஥ருந்துகள் அருந்துங் கானத்து ஥ீன், உப்பு, ஥ிகுசீ஡ம், 
஥ிகுப஬ப்தம், ஥ந்஡ப் பதாருள், ஋ண்ப஠ய், ஥துதாணம், வகப்பு, கார்ப்பு, புபிப்பு 
சுவ஬ப௅ள்ப பதாருள்கள், பதண் வதாகம் ஆகா7. 
 
இ஧ச ஢ஞ்சுப் பதாது குநி கு஠ங்கள்: 
 தூய்வ஥ பசய்஦ா஡தும் ஢ன்நாக ப௃டிக்கப் பதநா஡தும், அபவுக்கு 
அ஡ிக ஥ாணது஥ாண இ஧சத்வ஡ உண்த஡ணால் குற்நம் உண்டாகும். ஬ா஦ில் 
அச்ச஧த்வ஡ப் வதால் புண் உண்டாகும், தணங்கள்வபப்வதால் ஬ாய் கு஫ம்பும், 
஬ாய் ப஡ாண்வட இவ஬ ப஬ந்து ஬ஙீ்கும். ஬஦ிறு, குடல் இவ஬கள் புண்஠ாகும். 
தக்கத்஡ில் அடிக்கடி ஬னித்துக் பகாண்வட இருக்கும். ஬஦ிற்நின் ஥ீது தட்வட 
தட்வட஦ாக வ஡஥ல் தடரும். கானடி஦ில் ப஬டிப்பு கண்டு ஬ிட ஢ீர் கசிப௅ம். 
஢ீ஧வடப்பு, இ஧த்஡வத஡ி, உடல் ப஬ளுத்஡ல், காது பச஬ிடுதடல், கண் தார்வ஬ 
இ஫த்஡ல், சி஧ங்கு, புண் பசம்தவட வதால் உடனில் தவட உண்டா஡ல் ஆகி஦ 
குநிகு஠ங்கள் உண்டாகும். வ஥லும் தித்஡ன் வதான்று ஬ாய்தி஡ற்றும், 
து஠ிகவப கி஫ித்து அ஬ிழ்த் ப஡நி஦ச் பசய்ப௅ம். கல்னால் அடிக்கவும், 
஥வனவ஦நிக் கு஡ிக்கவும், ஡ண்஠ரீில் ஬ிழுந்து ப௃ங்கி ப௃ங்கி ப஬பி஬஧வும், 
஬ி஦ர்வ஬ பதருகும் ஆகி஦ குநிகு஠ங்கவபக் காட்டும். 
 
இ஧ச ஢ஞ்சு ப௃நிவு: 
 
 குண்டிவ஦ திடித்஡க்கால் சா஦ப்தட்வடவ஦ப் பதாடித்து 
ப஬ல்னத்துடவண கனந்து பகாடுக்க வ஬ண்டும். 
 தல்லுக்கிட்டிணால் வகாவ஬த்஡ண்டுச்சாற்வந ஢ாக்கில் தி஫ி஦த் 
஡ீரும். 
 ப஢ஞ்சு஬ற்நி, உள்ப஬தும்தி, வ஥ல்஋ரிவு஋டுத்து, வக கால் ஥ண்டி 
஋ரிந்து ஢ிவணவ்஬ில்னா஥ல் கிடந்஡ால் அறுகங்கி஫ங்வக ஆய்ந்து 
஋டுத்து அவ஧த்து ப஬ள்பாட்டுப்தால், தசு஬ின்தால். தருத்஡ிக் 
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பகாட்வடப்தால், வ஥ார், இவ஬கள் ஌஡ா஬ப஡ான்நில் கவ஧த்து 
஬டிகட்டிக் பகாடுக்க வ஬ண்டும். 
 ப஬ள்வப ப௃ட்சங்கன் இவனச்சாறு அல்னது ஥ி஡ிதாகனிவனச் 
சாறு இவ஬கபின் ஌஡ா஬ப஡ாறு சாற்வந 80஥ி.னி஬஡ீம் 
காவன஦ிலும்  ஥ாவன஦ிலும் 3஢ாள் பகாடுக்க வ஬ண்டும். 
 அவுரிவ஬ர்ப்தட்வடவ஦ ப஬ந்஢ீர் ஬ிட்டவ஧த்து சுண்வடக்காய் 
அபவு காவன஦ிலும் ஥ாவன஦ிலும் 3 ஢ாள் பகாடுக்க வ஬ண்டும். 
 துபசி வ஬ர்ப்தட்வடக் குடி஢ீர் 
 கரு வ஬ற் பகாப்புபிக் குடி஢ீர் 
 ஋ருக்குக் பகாப்புபிக் குடி஢ீர் 
 சுவ஧க் கருப்பு 
 ஡஦ிர் ப஬ல்னம்8 
 
வசரும் ஥ருந்துகள்:  
 குப்திச் பசந்தூ஧ம்9 
 சு஦஥ாக்கிணி பசந்தூ஧ம்10 
 சு஧ ஥ாத்஡ிவ஧10 
 சந்஡ிவ஧ா஡஦க் குபிவக11 
 தாடா஠ ஥ாத்஡ிவ஧11 
 இ஧சப் தற்தம்12 
 இ஧சச் பசந்தூ஧ம்12 
 ஡ிரிவ஢த்஡ி஧ ப஥ழுகு12 
 சஞ்சீ஬ி கு஫ம்பு13 
 த஧ஞ்வசா஡ி ஥ாத்஡ிவ஧13 
 ஥வனக்காத்஡ான் குபிவக13 
  சகன ஬ிடத்஡ிற்கு இ஧சத்஡ின் வ஥14 
 ஬ி஭க்கடிக்கு ஢ாதிக் கு஫ம்பு14 
 ஬ி஭க்கடிக்கு இ஧சா஡ிக் கு஫ம்பு14 
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MERCURY 
 
Physical appearance: 
 Metallic mercury is a heavy silvery liquid and is not poisonous, but it 
volatilizes at room temperature and inhalation of the vapor is highly toxic. 
 
Derivatives: 
 Mercuric chloride. 
 Mercurous chloride 
 Mercuric sulphide. 
 Mercuric oxide. 
Mercury in any form is toxic. There are 3 forms of mercury. 
o Elemental. 
o Inorganic. 
o Organic 
 
Elemental Mercury: 
 It is found in liquid form and easily vapourises to a monatomic state at room 
temperature. 
 
Inorganic Mercury: 
 Found mostly in salt form, it is highly toxic and corrosive. 
 
Organic Mercury: 
 It is lipid soluble, and mild corrosive. 
Absorption: 
 The main route of absorption (80%) of elemental mercury through respiratory 
tract. It is due to its monatomic form and lipid solubility. But it is poorly absorbed in 
GI tract and is mildly toxic through ingestion as it occurs as larger globular particles. 
Inorganic mercury gains entry in the body either orally or dermally. Organic mercury 
is absorbed completely in GI tract.
15
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Distribution: 
 Mercury as a heavy metal tents to accumulate in the lowest part of the body, 
such as floor of the mouth, pelvic floor and feet 
     (Alternative medicine magazine 1997) 
 Mercury is a toxic metal widely occurring in the biosphere which presents 
hazards associated with both ingestion and inhalation. 
 Pesticides, large fish and mercury dental filling are the most potent sources of 
mercury. 
 Mercury has also been used as an antiseptic and pesticide. Many commercial 
preparation have contained the inorganic mercury salt calomel (Mercurous chloride), 
including over the counter laxative preparations and some cosmetics. 
 The  largest source of mercury for most people in the western world amalgam 
(Silver) dental filling. The normal chewing of food cause the abrading of amalgam 
from the filling leading to the ingestion of small particles of mercury. Natural 
endogenous bacteria of the mouth and gut are able to convert inorganic mercury into 
organic mercury through methylation. (Adding a methyl group to the mercury 
element) and so forming methyl mercury. 
 The WHO states that the largest estimated average daily intake and retention 
of mercury and mercury compounds in the general population Is from dental amalgam 
filling. The estimated daily intake of mercury from dental amalgams is 3.8 – 21 mcg 
per day.
16 
 
Uses: 
1. Medicinal Uses: 
o Disinfectant. 
o Dental filling. 
o Diuretic. 
o Treatment of syphilis. 
 
2. Industrial Uses: 
o Thermometer. 
o Barometer. 
o Calibration instruments. 
o Fluorescent and mercury lamp. 
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3. Miscellaneous: 
o Golden silver extraction   
o Photography 
o Insecticide and pesticide 
o Embalming 16 
 
TOXICOLOGICAL ASPECTS 
 
Acute toxicity: 
Ingestion: 
 Metallic taste, burning pain in the mouth extending down to the stomach and 
abdomen followed by nausea, vomiting and then diarrhea. The urine is suppressed or 
scanty. 
 
Inhalation: 
 Metallic taste, salivation, gingivitis and loosening of teeth, lethargy,  slurring 
of speech, diarrhea, pneumonitis, cough, cyanosis and anuria. 
 
Chronic toxicity: 
1. Hydragyrism: 
 Salivation,Metallic taste, steatites, gingivitis, bluish black gum line (Burtonian 
line), loosening of teeth. 
2. Tremer: 
 The advanced condition called “Hatter’s shake” the person then becomes 
unable to dress him write legibly or walk properly. 
3. Mercurialentis: 
 Discoloration  of the lens of the eye when viewed through a slit lamp.
 
4. Acrodynia: 
Mercurous chloride used to be given to children in the past as teething powder. 
This gave rise to a condition called acrodynia (pink disease) characterized by fever, 
skin rash, joint pain and spleenomegaly. The cheeks, tip of the nose, hands and feet 
appear intensely pink.
17
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Biological effects: 
 Mercury has toxic effects on numerous organs and system. Themajor target 
organs being CNS and kidney. Both organic and inorganic compounds have an avid 
affinity for thiol chemical groups and this is the property, which send them toxic. 
Most mercury compounds are potent but unspecific inhibitors affecting membrane 
permeability, nerve conduction and tissue respiration. In this aspect biochemical 
effects of mercury resemble those of “black widow spider venom”. 
 
Highest concentration of mercury occurs in kidney regardless of chemical 
form absorbed. Kidney is the primary target organ only in the case of inorganic 
mercury. 
            
Renal tissue contains a thiol rich protein called metallothionein. Exposure to 
toxic metals trigger the production of protein,which binds tightly to the metal 
retaining in kidney in relatively harmless form. As long as the kidney’s capacity for 
the production of metallothionein is not overwhelmed, mercury excretion eventually 
balance intake, thereby limits worsening of symptoms. However, acute high dose or 
increase in chronic dose level Precipitates renal failure, which is a classical symptom 
of mercurial poisoning. Massive oral doses of inorganic mercury initiates a chain of 
events with anural progressing to polyuria then finally recovery to normal renal 
function. 
  
More useful form mercurial toxicity occurs with chronic industrial exposure, 
which is characterized by polyuria. If severe, nephritic syndrome is observed.
18 
 
Toxic symptoms of mercury in various systems: 
If a person has seven or more of these symptoms, there is a significantly 
increased possibility that mercury toxicity is a major contributing factor. 
 
Central nervous system: 
 Irritability. 
 Anxiety/ nervousness, often with difficulty in breathing. 
 Restlessness. 
 Exaggerated response to stimulation 
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 Fearfulness. 
 Emotional instability: 
1. Lack of self control. 
2. Fits of anger, with violent, irrational behaviour 
 Loss of self confidence 
 Indecision. 
 Shyness or timidity, being easily embarrassed 
 Loss of memory. 
 Inability to concentrate. 
 Lethargy, drowsiness. 
 Mental depression, despondency 
 Suicidal tendencies. 
 Manic depression.  
 Numbness and tingling of hands, feet, fingers, toes or lips. 
 Muscle weakness progressing to paralysis. 
 Ataxia 
 Tremors/trembling of hands, feet, eyelids or tongue. 
 In coordination 
 Myoneural transmission failure resembling myasthenia gravis. 
 Multiple sclerosis. 
 
Head, Neck, Oral cavity disorders: 
 Bleeding gums. 
 Alveolar bone loss. 
 Loosening of teeth. 
 Excessive salivation 
 Foul breath 
 Metallic taste 
 Burning sensation, with tingling of lips, face. 
 Tissue pigmentation (amalgam tattoo of gums) 
 Leukoplakia. 
 Ulceration of gingivitis, palate, tongue. 
 Dizziness. 
 Hearing difficulties. 
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Gastrointestinal effects: 
 Food sensitivities, especially to milk and eggs. 
 Abdominal cramps, colitis, diverculitis or other gastro intestinal 
complaints. 
 Chronic diarrhea / constipation. 
 
Cardiovascular effects: 
 Abnormal heart rhythm 
 Characteristic finding on ECG 
 The Abnormal changes in the S-T segment and / or lower 
 Broadened P wave. 
 Unexplained elevated serum triglycerides. 
 Unexplained elevated cholesterol. 
 Abnormal blood pressure, either high or low. 
 
Systemic effects: 
 Chronic headaches 
 Allergies 
 Severe dermatitis 
 Thyroid disturbances 
 Cold, clammy skin, especially handsome feet 
 Chronic kidney disease. 
 General fatigue. 
 Loss of appetite. 
 Loss of weight. 
 Hypoglycemia.18 
 
Mechanism of toxicity: 
 Mercury can be found in a two main forms, inorganic and organic. Inorganic 
mercury is very toxic to humans, but not nearly as toxic as organic mercury such as 
methyl mercury. Methyl mercury is a form of mercury which has been bound to a 
simple organic carbon group. This makes it permeable to membranes and encourages 
its movement into brain tissues. About 10% of mercury ingested accumulates in the 
brain. 
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 Mercury has an affinity for organic sulphur compounds called thiols, which 
are essential compounds of enzyme systems. Mercury will irreversibly blind to these 
thiol groups, and inhibit their function in enzyme reactions, Thiols are also involved 
in protein formation and help stabilize protein structure. Mercury is then able to cause 
the denaturation of protein structures particularly in the brain. It can also form a 
hapten with the protein it is bound to causing the immune system to recognize that 
protein as foreign particle destroying it at all opportunities. This leads to beginning of 
autoimmune disorders. 
 
Mercury detoxification: 
  In attempt to reverse the problem of mercury toxicity it is important to realize 
that the mercury contamination must be removed. 
 
   Whether this is the cessation of using cosmetics, eating fish or having dental 
amalgams removed. 
 
It is also important to supplement those nutrients most affected by mercury as 
this appears to one way of reducing the effects of chronic exposure. High protein diet 
is recommended. As Sulphur bearing amino acid in protein will greatly facilitate 
detoxication, as mercury will attach to sulphuramino acids in protein, it is important 
to supplement with nutrients to encourage mercury elimination. 
 
Glutathione (USH): 
 Glutathione is an important antioxidant amino acid which protects against 
mercury toxicity. 
 
N-acetyl L-cysteine (NAC): 
 In experiments where animals were exposed to mercury vapor, NAC treatment 
increased, animal survival time and decreased the mercury levels in blood, lung and 
kidney tissues from these animals. 
 
L.Methione: 
 L.Methione is an essential sulphur containing amino acid. It is used by the 
body to produce cysteine, cystathionine, glutathione and taurine. Mercury is able to 
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bind to methionine and inhibit it being used in the production of cysteine and 
glutathione. 
 
Zinc: 
 Mercury is able to compete with displace zinc in a number of biological 
systems. Thus mercury causes zinc deficiencies in various tissues such as the brain. 
Zinc stimulates the production of metallothionein is very rich in cysteine. 
Supplemental zinc is therefore vital in any mercury elimination programme. 
 
Ascorbic acid (Vitamin C): 
 Prolonged exposure to mercury tends to depress the adrenal. Ascorbic acid 
content providing vitamin C should help restore and or maintain adequate adrenal 
levels of this critical nutrient, thus offsetting the depletion of this chemical due to 
streeses caused by chronic inhalation of mercury vapor. 
 
Selenium: 
 This essential mineral is able to bind to mercury and is able to cause a 
redistribution of tissue mercury. It is therefore able to precipitate the excretion of 
some mercury from the body. 
 
Garlic: 
 Garlic’s powerful actions come from its sulphur contains constituents, 
including allicin, allin, and daallydisulphidde. These comounds are quite capable of 
binding to and eliminating mercury as a normal part of their physiological action. 
 
 A number of other nutrient help support. These  include thiamine (Vitamine 
B1), magnesium, potassium and chromium. Fatigue is a common symptom of 
mercury toxicity and one that can e alleviated with aid of Ginko Biloba, cats claw 
(Uncaria tomentosa) and Co enzyme Q10, all of these nutrients are capable of 
increasing energy levels in the body, following the patient to feel increased vigour.
16 
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The circumstances of poisoning: 
 Accidental poisoning by mercuric chloride may be due to the use of strong 
solution in washing abscess cavities or irritating vagina, uterus or rectum. Homicidal 
and suicidal poisoning is rare. 
 
Post mortem appearances: 
 The mucosa of GI tract shows inflammation, congestion, corrosion, acute 
tubular and glomerular degeneration or heamorrhagic glomerular nephritis is seen. 
The liver is congested and shows cloudy swelling or fatty change.
 19
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                                                        கந்தகம் 
 
வயறுப஧னர்: 
             காரிழமனின்஥ாதம், ஧ழபயரீினம், அதீதப்஧ிபகாசம், ஧ஜீம், பசல்யியிந்து, 
சக்தி, சத்தி஧சீம், பசந்தூபத்தாதி, த஦ம், வதயிம௃பம், ஥ாதம், ஥ாற்஫ம், ஧ழப஥ாதம், 
ப஧ான்யர்ணி, இபசசுவபாணிதம். 
  
஧ாடாணங்கள் அறு஧த்து ஥ான்கில் ஧ி஫ப்புகந்தகம், ழயப்புகந்தகம், 
வகாமித்தழ஬ பகந்திழயப்பு, யாணபகந்தி ழயப்பு ஋ன்று ஥ான்கு ஧ாடாணங்கள் 
கூ஫ப்஧ட்டுள்஭து. 
 
கந்தகத்தின்யழககள்: 
பயண்ழந ஥ி஫ம்  - ஋ல்஬ா வ஥ாய்கழ஭ம௃ம் 
தீர்க்கும் 
 கி஭ி மூக்குச் சியப்பு஥ி஫ம்  - ஥யவ஬ாகத்ழத ஌நநாக்கும் 
ப஧ான்ழந ஥ி஫ம்   -  குற்஫நற்஫ ப஥ல்஬ிக்காய் 
வ஧ான்று இருக்கும், 
சூதகத்வதாடு உ஫யாகி 
சுத்தநாய் இருக்கும் 
 காகத்தின் ஥ி஫ம்   -  ஥ழப திழப அற்றுப்வ஧ாகும் 
 
 ஧தார்த்த குண சிந்தாநணினில் ப஥ல்஬ிக்காய் கந்தகம், யாண கந்தகம் 
ஆகினயற்஫ின் குணங்கள் கூ஫ப்஧ட்டுள்஭஦. நருந்துக஭ில் ழகனா஭ப்஧டுயது 
ப஥ல்஬ிக்காய் கந்தகநாகும். 
 
஥ட்புச்சபக்கு: 
  “கந்தகத்தி஦ முநிபசந்தா ப஦ன்஫ாவப” 
   கந்தகத்தின் ஥ட்புச்சபக்கு பசம். 
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஧ழகச்சபக்கு: 
  “பசால்லுவந தாம்஧ிபத்ழதக் பகந்திபகால்லும்” 
        கந்தகந்தின் ஧ழகச்சபக்கு பசம்பு. 
 
சுழய: 
 ழகப்பு, துயர்ப்பு 
 
பசய்ழக: 
 ந஬நி஭க்கி 
 உடல்வதற்஫ி 
 யினர்ழயப஧ருக்கி 
 கிருநி஥ாசி஦ி 
 ஧ித்த஥ீழப அதிகப்஧டுத்தும் 
 அசுகங்க஭ின் ச஭ிச்சவ்யிலுள்஭ வகா஭ங்க஭ின் சுபப்ழ஧ 
அதிகப்஧டுத்தும். 
 யிவபகினில் சி஫ப்஧ாக பசனல்஧ட்டு சுபப்ழ஧ அதிகப்஧டுத்தும். 
 
ப஥ல்஬ிக்காய்கந்தகத்தின்குணம்: 
 “ப஥ல்஬ிக்காய்க் பகந்திக்கு ஥ீள்஧திப஦ண் குட்டநந்தம் 
  யல்ழ஬ கயிழசகுன்ந யாம௃கண்வணாய் – ப஧ால்஬ா 
  யிடக்கடுயன் வநகவ஥ாய் யறீுசுபம் வ஧தி 
  திடக்கிபக ணிக஧ம்வ஧ாந் வதர்” 
- ஧தார்த்த குண சிந்தாநணி 
ப஧ாருள்:  
஧திப஦ண்குட்டம், நந்தம், கல்஬ீபல்யகீ்கம், குன்நயாம௃, 
கண்வணாய்கள்,பகாடுழநழன பசய்கின்஫ யிடக்கடிகள், ஥ாட்஧ட்ட வநக 
வ஥ாய்கள், யாதசுபம், வ஧தி, ஥ாட்஧ட்ட கிபகணி, க஧ம் முத஬ின஦ ஥ீங்கும். 
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யாணக்கந்தகத்தின்குணம்: 
 “யாணக் குமாய்கந்தி யாசழ஦ழனக் கண்டவுடன் 
 காணக் கிருநி பசா஫ி காணாயாம் – வதாணும் 
 ப஧ருயினா திக்கூட்டம் வ஧ருநத னூ஬ின் 
 நருயினா ழுங்பகாடிவன யாழ்த்து” 
 
ப஧ாருள்:  
              யாண நருந்துக்கா஦ குமாய்கந்தகத்தின் யாசழ஦ழனக் கண்டவுடன் 
இபச இபத்தத் தாதுக்க஭ில் ஧ி஫ந்தக் கிருநிகள், பசா஫ி, குழ஫வ஥ாய்க் 
குட்டங்கள், ஥ாட்஧ட்ட கீல் யாதம், சுயாசகாசம், நாபழடப்பு, கண்டநாழ஬, 
குதப஥கிழ்ச்சி வ஧ான்஫ வ஥ாய்கள் ஥ீங்கும். 
   
“நாதர் நகழய ய஭ர்ப்஧துவ஧ா வ஬ம௃டம்ழ஧ 
 னாதபயா கத்வதற்஫ி னாக்ழகனி஦ால் – நீதாக 
 வநயி னடர்வ஥ானின் பயப்஧த்ழத நாற்றுத஬ாற் 
 வ஫யிம௃ப பநன்஧துடல் வதர்” 
- வதபன் ப஧ாருட்஧ண்பு நூல் 
 
ப஧ாருள்:  
கந்தகம் தாய் நகழய ய஭ர்ப்஧து வ஧ா஬ வ஥ாய்க஭ின் பயப்஧த்ழத 
நாற்஫ி உடம்ழ஧த் வதற்றுயிக்கும். 
 
சுத்திமுழ஫கள்: 
 கந்தகத்ழத ஒரு இரும்புக்கபண்டினில் இட்டு சி஫ிது 
஧சுபயண்பணய் இட்டு உருக்கிப் ஧சும்஧ா஬ில் 
சாய்க்கவும்.இவ்யிதம் 30 முழ஫ பசய்ன கந்தகம் 
சுத்தினாகும்.ஒவ்பயாரு முழ஫ம௃ம் புதின஧ாழ஬வன உ஧வனாகிக்க 
வயண்டும். 
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 ஧ாலுக்கு ஧தில் யாழமக்கட்ழட஥ீரில் கந்திழனப் ஧த்துமுழ஫ 
உருக்கி உருக்கிச் சாய்த்து ஋டுக்கு சுத்தினாம்.இம் முழ஫ 
கந்தகத்தில் உள்஭ ஋ண்பணய் ஥ீங்கும். 
 நருவதான்஫ிக் கற்கத்ழத ஧சுயின்தனிரில் க஬ந்து ஒரு சட்டினில் 
இட்டு சீழ஬னில் வயடுகட்டி, அதன் வநல் கந்தகத்ழத ழயத்து 
நற்ப஫ாருசட்டினால் மூடி சீழ஬ பசய்து குமினில் புழதத்து, 
வநல்சட்டி வநல் 5 ய஫ட்டி பகாண்டு புடநிட கந்தகம் உருகிக் கீவம 
இ஫ங்கும். இவ்யிதம் 7 முழ஫ பசய்ன வயண்டும். 
 பு஭ினம்஧ம ஓட்ழடப் ஧ற்஫ினிருக்கும் கசிழய ஊ஫யத்துஇறுத்த 
஥ீர், காடி஥ீர், பு஭ித்தவநார், கா஭ான்சாறு இழயகழ஭ த஦ித்த஦ி 6 
஧஬நாக ஋டுத்துக்க஬ந்து ஒரு சட்டினி஬ிட்டு அச்சட்டிக்கு 
சீழ஬னி஦ால் வயடுகட்டி அதன்வநல் ஒரு஧஬ம் கந்தகத்ழத 
ழயத்து வநல்மூடி அடுப்வ஧ற்஫ி தீ஧ாக்கி஦ினாய் 2 சாநம் ஋ரிக்க 
ந஬ி஦ம்  வநல் தங்கி கந்தகம் சுத்தினாகிக் கீமி஫ங்கும். 
 
அ஭வு: 
10 (650நிகி) முதல் 30 (1.9கி) உளுந்பதழட7 
வசரும் நருந்துகள்:  
 கந்தக ழத஬ம்9 
 சுனநாக்கி஦ி பசந்தூபம்10 
 கந்தக பசானணம்20 
 சந்஥ி஧ாத ழ஧பயம்21 
 கந்தக பசந்தூபம்22 
 சண்டநாருத பசந்தூபம்23 
 நால்வதயி பசந்தூபம்23 
 கந்தக பநழுகு24 
 ஆறுமுக பசந்தூபம்25 
 ஥ாதகுரு ழத஬ம்25 
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                                                        SULPHUR 
  
          Sulphur is a chemical element with symbol S and atomic number 16. It is an 
abundant, multivalent non-metal. On Earth, elemental sulfur can be found near hot 
springs and volcanic regions in many parts of the world, especially along the Pacific 
Ring of Fire; Native sulfur is synthesized by anaerobic bacteria acting on sulfate 
minerals such as gypsum in salt domes. Common naturally occurring sulfur 
compounds include the sulphide minerals, the sulphates and barite. 
 
SOURCE:  
         A non metallic element found free in beds of gypsum and in a state of 
sublimation in regions of extinct volcanoes; also in combination with several ores 
called pyrites, as sulphates and sulphides of iron, copper, lead, zinc, mercury, etc.  
 
REGIONAL NAMES:  
Tamil    :  Gandhagam  
English   :  Brimstone; sublimed sulphur  
Hindi    :  Gandak  
Sanskrit  :  Gandhaka  
 
PHYSICAL PROPERTIES:  
Sulphur forms polyatomic molecules with different chemical formulas, with 
the best-known allotrope being octasulphur, cyclo-S8. Octasulphur is a soft, bright-
yellow solid with only a faint odor. It melts at 115.21 °C (239.38 °F), boils at 444.6 
°C (832.3 °F) and sublimes easily. All of its stable allotropes are excellent electrical 
insulators. 
   
CHEMICAL PROPERTIES:  
Sulphur burns with a blue flame concomitant with formation of sulphur 
dioxide, notable for its peculiar suffocating odor. Sulphur is insoluble in water but 
soluble in carbon disulphide and, to a lesser extent, in other nonpolar organic solvents, 
such as benzene and toluene.   
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Sulphur in blood: 
 Total level – 3.4 mg%. it exists in three distinct forms. 
A) Inorganic sulphate – 1 mg % 
B) Neutral sulphate -1.9 mg% 
C) Ethereal sulphate -0.5 mg% 
 
ACTION:  
            Sulphur is described as of bitter astringent taste with a peculiar strong smell.  
It increases bile, act as a laxative and alternative and its preparations also act as 
alternative, laxative, diuretic and insecticide.  Sulphur, when taken internally and in 
small doses, becomes absorbed and may be detected in the sweat, milk and urine.  It is 
a stimulant to the secreting organs such as the skin and bronchial mucous membranes.  
It has a specific action on the rectum and increases the hemorrhoid secretions.  The 
sulphurous and mineral waters as they contain earthy and   Alkaline sulphates act as 
laxative and diuretic, while the sulphurous acid disengaged from them acts as a 
diaphoretic.  In large doses it acts as a purgative.  
 
USES:  
         It readily combines with and fixes metallic mercury and is therefore extensively 
used in combination with that metal.  In combination with cream of milk, sulphur is 
given in diseases like hemorrhoids, prolapsed and stricture, also in chronic skin 
diseases; in skin diseases sulphur is used both internally and externally. Sulphur is 
useful in cough, asthma, consumption and general debility; also useful in enlargement 
of the liver and spleen, chronic fevers etc.  As sulphur is a mild laxative, for habitual 
constipation, in the presence of hemorrhoids, equal parts of sublimed sulphur and 
cream of tartar with a little honey or milk in doses of 1 drachma is taken before each 
meal.  Dose is half to one teaspoonful once or twice daily.  This also acts beneficially 
in cases of piles and chronic dysentery. A sulphur bath is generally efficacious for 
skin diseases, as itch, acne, rosacea, sycosis and chloasma and internally sulphur 
powder or mineral sulphureted waters are given with benefit.  In many households 
sulphur is used to disinfect rooms by fumigation.  In cases of chronic rheumatism a 
liniment composed of two ounces of powdered or sublimed sulphur and a pint of 
neem oil well rubbed in, twice daily, is very beneficial.
26 
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METABOLISM AND BIOLOGICAL FUNCTION:  
Sulphur is metabolized by all organisms, from bacteria to plants and animals. 
Sulfur is reduced or oxidized by organisms in a variety of forms. The element is 
present in proteins, nucleic acids, sulfate esters of polysaccharides, steroids, phenols, 
and sulfur containing coenzymes. Sulfur is an essential element for all life, and is 
widely used in biochemical processes. In metabolic reactions, sulfur compounds serve 
as both fuels and respiratory materials. Sulfur in organic form is present in the 
vitamins biotin and thiamine. Sulfur is an important part of many enzymes and in 
antioxidant molecules like glutathione and thioredoxin. Organically bonded sulphur is 
a component of all proteins, as the amino acids cysteine and methionine. Disulphide 
bonds are largely responsible for the mechanical strength and insolubility of the 
protein keratin, found in outer skin, hair, and feathers.
27 
 
PHARMACEUTICALS:  
  Sulfur (specifically octa sulfur, S8) is used in pharmaceutical skin 
preparations for the treatment of acne and other conditions. It acts as a keratolytic 
agent and also kills bacteria, fungi, scabies mites and other parasites. Precipitated 
sulfur and colloidal sulfur are used, in form of lotions, creams, powders, soaps, and 
bath additives, for the treatment of acne vulgaris, acne rosacea, and seborrhoeic 
dermatitis. 
28,29
     
 
Common adverse effects include irritation of the skin at the application site, 
such as dryness, stinging, itching and peeling.    
 
TOXICOLOGICAL ASPECT OF GANDHAGAM:  
Elemental sulfur is non-toxic, as generally are the soluble sulfate salts. Soluble 
sulfate salts are poorly absorbed and laxative. However, when injected parent rally, 
they are freely filtered by the kidneys and eliminated with very little toxicity in multi-
gram amounts.  
When sulfur burns in air, it produces sulphur dioxide. In water, this gas 
produces sulfurous acid and sulfites, which are antioxidants that inhibit growth of 
aerobic bacteria and allow its use as a food additive in small amounts. However, at 
high concentrations these acids harm the lungs, eyes or other tissues.
30
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சேபாங்க ாட்டை 
 
சயறுக஧னர்: 
 சேங்க ாட்டை ,யல்஬ாதி, யல்஬தா ி, ஋ரிப௃ ி, ஧ல்஬தா ி, 
 ிட்ைாக் ஦ிக் க ாட்டை, ஥ந்தியித்து. 
 
஧னன்஧டும்உறுப்பு: 
 க ாட்டை, ஧ருப்பு 
 
சுடய: 
 ட ப்பு, யிறுயிறுப்பு 
 
தன்டந: 
 கயப்஧ம் 
 
஧ிரிவு: 
  ார்ப்பு 
 
கேய்ட : 
 உைற்சதற்஫ி, புண்ணாக் ி 
 
குணம்: 
 
 “குட்ைங் ன சபா ங் க ால்லும் யிை஧ா ந் 
 துட்ைந்தரு  ிருநி சூட஬ப௅ம் ச஧ாம் – நட்ை஬ருங் 
 கூந்தன் நனிச஬  ிபந்திக் கூட்ைம் ச஧ாஞ் கேங்ட னில் 
 ஌ந்து சேங்க ாட்டை தட஦சன” 
- அ த்தினர் குண யா ைம் 
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க஧ாருள்: 
  க஧ருச஥ாய், இட஭ப்புச஥ாய், ஥ஞ்சு ள், சூட஬, திநிர்஧டை,  ரும்஧டை, 
கயண்குட்ைம், தீபாக் டி, ப௄஬ம், ய஭ிச஥ாய் ள், குன்நம் இடய ட஭ 
ச஧ாக்கும். 
 
குணம்: 
“சேபா தமகு யடியினுக்குச் சேரு நதி ப் ஧ேிப௅ண்ைாம் 
சேங் ன் க஫ன்஦ வுபப௃ண்ைாஞ் சே ண்டிடனப் ச஧ால் 
கதா஦ி ப௅ண்ைாம் 
 சேை க஦஦சய னின்஧கந஬ாஞ் சேர்ந்சத அடணன கநன்சநலும் 
 சேனின் ப௃ ம்ச஧ால்  ட஭ப௅ண்ைாம் சேர்க்ச  த஦ன்ச஧ால் 
஋மிலுறுசந” 
- சதபன்  ரிேல் 
 
க஧ாருள்:  
சேபாங்க ாட்டை ச஬ ினத்டத ப௃ட஫ப்஧டி க ாள்஭ின் அமகும் ஧ேிப௅ம் 
உண்ைாம்.கேங் ன்ட஫ கனாத்த உபம்஋ழும் ,கேய்ச஧ரிட னின் ஒ஬ிடனப் 
ச஧ால் குபல்ஒ஬ி க஧ருகும். ஆதிசேைட஦ப் ச஧ால் இன்஧ந் துய்க்  ய஬ிவு 
உண்ைாகும், குமந்டதனின் ப௃ ம் ச஧ால் ட஭ப௅ம், நன்நதன் ச஧ான்஫ ஋மிலும் 
உண்ைாகும். 
 
  ாற்஧ாே நா க்  டுப்பு ா ஬ின்ப௃ன்ச஦ 
  ாற்஧ாே நா க்   தறுசந-  ாற்஧ாேஞ் 
 சேபா யிடபக் ற்஧ஞ் ேீபாயா கநய்க் த஦ாற் 
 சேபா யிடபக் ற்஧ந் தின் 
- சதபன் னந  கயண்஧ா 
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க஧ாருள்:  
இதட஦  ற்஧நா க் க ாள்஭,  ா஬ிச஬ யி஬ங் ிருப்஧டதப் ச஧ான்று 
஥ைக் கயாட்ைாநற்஧டி  ால் ட஭ ப௃ைக்கும் ய஭ிச஥ாய் ளும், அத஦ால் 
உண்ைாகும் குத்தலும் க஧ருங் ாற்ட஫ ஋திர்த்த ஧ஞ்ோகும்.  
 
சுத்திப௃ட஫ ள்: 
 சேங்க ாட்டை சநல் நபம்ச஧ால் உள்஭ ப௄க்ட  ேீயி, 
சுண்ணாம்புக்கு ஥டுயில் டயத்து  ள் அல்஬து  ாடியிட்டு 
தா஭ித்துக்  ழுயி ஋டுக் வும் .இவ்யா஫ா  ஆறு ப௃ட஫ கேய்னத் 
தூய்டநனாகும். 
 பு஭ினிட஬, புபேம்பூ இடய ஭ின் குடி஥ீரிலும், 
஧சுஞ்ோணப்஧ா஬ிலும்  ற்஫ாடமச்ோற்஫ிலும் ப௃ட஫சன 
சய டயத்து஋டுக் ஬ாம். 
 சேபாங்க ாட்டை ஓப஭வு, இபட்டைன஭வு ஧஦ங் ள்ளும், ேி ப்பு 
஧சுந்தனிறும் கூட்டி ஒண்஧து ஥ாள் சூரின஦ில்  ாய்ந்த ஧ின்  ழுயி 
஋டுத்துக் க ாள்஭ சயண்டும். இம் ப௃ட஫ சதபன்  ரிே஬ில் 
கூ஫ப்஧ட்டுள்஭து.31 
 
஥ஞ்சுக் கு஫ிகுணம்: 
 உைம்஧ில் ஧ட்ை நாத்திபத்திச஬ சயக் ாடை  உண்ைாக் ி  புண்ணாக்கும். 
நருந்து கேவ்யச஦ ஧க்குயப் ஧ைாயிட்ைால் உட்க ாண்ைவுைச஦ யாய், யனிறு, 
குைல் ப௃த஬ினன்ப் புண்ணாகும். ேி஬ ேநனம் நந்தம், ஋ரிச்ேல், யாந்தி,  மிச்ேல் 
ப௃த஬ினடய ட஭ உண்ைாக்கும். உைம்ட஧ ஊதச் கேய்ப௅ம்.தூக் த்டத 
க டுக்கும். ோடய உண்ைாக்கும். 
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ப௃஫ிவு: 
 சேபங்க ாட்டை க஥ய் உைல் சநற்஧ட்டு உைல் ஊதியிட்ைால் 
கேங் ல்ட஬ப் க஧ாடி கேய்து  உை஬ில் ஒற்஫ைம் ச஧ாட்டு கநழுட ப௅ம் 
஥ல்க஬ண்டணப௅ம் சேர்த்துக்  ாய்ச்ேி  சநலுக்குப் பூேி஦ால் ஊதி஦ உைல் 
யற்஫ிடும்.  
 
சேபாங்க ாட்டைப் ஧ா஬ால் உண்ைாகும் புண்ணுக்கு ப௃஫ிவு: 
 ச ாடபக் ிமங்கு, ேந்த஦ம், ஋ள், ஌஬ரிேி, ேரிகனடை கூட்டி ஥ீர் 
யிட்ைடபத்துத் சத஦ில்  ஬ந்து உைல் சநல்பூே புண் ஥ீங்கும். 
 சேங்க ாட்டைடன உட்க ாண்டுயிட்ைால் பு஭ினிட஬டன 
஥ன்஫ா  இடித்து அதன் அ஭யிற்கு ஋ட்டு஧ங்கு ஆற்று஥ீர் சேர்த்து 
அதில் சநற்சதால் ேீயி஦ ஒரு இ஭஥ீடப ச஧ாட்டு சய டயத்து 
அத்சதங் ானின் யழுக்ட டனத் தின்று அந்஥ீடபப௅ம் உட்க ாள்஭ 
சேங்க ாட்டைனின் சய ம் த஦ிப௅ம்.8 
 
சேரும் நருந்து ள்:  
 ந ாயல்஬ாதி ச஬ ினம் 
 இபே ந்தி கநழுகு 
 ஥ந்தி கநழுகு 
 ேீ஦ யல்஬ாதி கநழுகு 
 ஥ீபடிப௃த்து யல்஬ாதி 
 ேப஧பாஜ கு஭ிட 32 
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                                        SEMECARPUS ANACARDIUM 
 
Names in different languages: 
 English name   : Marking nut. 
 Tamil name   : Chenkottai. 
 Malayalam name  : Chermara. 
 Sanskrit name   : Bhallataka. 
 Telugu name   : Jeetivittulu. 
 Arabian name   : Beladin. 
 Gujarati name   : Bhiamu. 
 Persian name   : Biladur. 
 Panjabi name   : Bhela. 
 Marathi name   : Bibba. 
 Hindi name   : Bhela. 
 
Habitat: 
This tree is found growing on the sub Himalayan and tropical parts of india 
 
Taxonomy of Semecarpus anacardium: 
 Kingdom  :  Plantae 
 Subkingdom  : Tracheobionta. 
 Super division    : Spermatophyte. 
 Division             : Magnoliophyta. 
 Class                 : Magndiopsida. 
 Subclass            : Rosidae. 
 Order                 : Sapindales. 
 Family              :   Anacardiaceae. 
Genus              : Semecarpus. 
Species            :  Anacardiace. 
 
.  
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Parts used: 
 Fruit (seed). 
 Gum. 
 Oil. 
 
Description: 
It is a moderate-sized deciduous tree found in the outer Himalayas and hotter 
parts of India up to 3500 ft. height. The plant is found in abundance in Assam, Bihar, 
Bengal and Orissa, Chittagong, central India and western peninsula of East 
Archipelago, Northern Australia. 
 
It is a medium-to-large size tree, 15–25 m in height with grey bark exfoliating 
in small irregular flakes, leaves simple alternate, obviate – oblong, 30–60 cm long and 
12–30 cm broad, rounded at the apex curvaceous glabrous above and more or less 
pubescent, beneath. The flowers are greenish white, in panicles and appear with new 
leaves in May and June, easily recognized by large leaves and the red blaze exuding 
resin, which blackens on exposure. 
 
 The nut is about 2.5 cm long, ovoid and smooth lustrous black. It is frequently 
found in drier rather than damp localities. The fruit ripens from December to March 
and are 2–3 cm broad. No specific soil affinity. It is a moderate shade bearer, 
obliquely ovoid or oblong drupe, 2.5 to 3.8 cm long, compressed, shining black when 
ripe, Seated on an orange-colored receptacle form of the disk, the base of the calyx 
and the extremity of the peduncle. The bark is grey in color and exudes an irritant 
secretion on incising
(33)
. 
 
Phenology: 
Flowering season   :From May to August . 
Fruiting season : From August to February. 
Seeding Season : From August to February. 
Leaf falling  : During hot season. 
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Phytochemistry: 
The most significant components of the S. anacardium. Linn. are 
 Bhilwanols 
 Phenolic compounds 
 Biflavonoids 
 Sterols and Glycosides. 
 
PHARMACOLOGY: 
Anti atherogenic effect 
The imbalance between the pro-oxidants and antioxidants is the main cause of 
development of atherosclerosis. To prevent such condition, antioxidant therapy is 
beneficial. Semecarpus anacardium (SA) shows such antioxidant property. It has 
capacity to scavenge the superoxide and hydroxyl radicals at low concentrations. The 
process of atherogenesis initiated by per oxidation of lipids in low-density 
lipoproteins was also found inhibited  by  semecarpus anacardium. Cardiac activity of 
SA, as it generally reduces   the tissue and serum hyperlipidemia by the inhibition of 
intestinal cholesterol absorption coupled with peripheral disposal thus possessing anti-
artherosclerotic activity
(34)
. 
 
It is possible that the beneficial anti atherogenic effect may be related to its 
antioxidant, anticoagulant, hypolipidemic, platelet anti-aggregation and lipoprotein 
lipase releasing properties. The mechanism of hypotriglyceridemic effect has also 
been shown to be partly due to stimulation of lipoprotein lipase activity. 
 
Anti inflammatory activity 
 The anti inflammatory effects of SA nut extract on developing and developed 
adjuvant arthritis. Semecarpus anacardium significantly decreased the carrageen an-
induced paw edema and cotton pellet granuloma. These results indicate the potent anti 
inflammatory effect and therapeutic efficacy of SA Nut extract against all phases of 
inflammation is comparable to that of indo methacin
(35)
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The ethyl acetate extract of SA led to the isolation of major active principle, 
tetra hydroamentoflavone (THA), a biflavonoid. The in vitro cyclooxygenase (COX-
1)-catalyzed prostaglandin biosynthesis assay of THA gave an IC50 value of 29.5 μM 
(COX-1) and 40.5% inhibition at 100 g/mL (COX-2). The in vivo carrageenan-
induced paw edema assay resulted in dose-dependent anti inflammatory effect of 
THA and the activity was comparable to that of ibuprofen
(36)
. 
 
The  methanolic, ethanolic, chloroform, ethyl acetate and petroleum ether 
extracts of fruits of SA and tested to study the anti inflammatory activity using the 
technique of carrageenan-induced paw edema in albino rats. The extract showed 
significant anti inflammatory activity comparable to the reference standard aspirin
(37)
. 
The anti inflammatory activity of Semecarpus anacardium for both immunological 
and non immunological origin.The  SA extract can inhibit pro inflammatory cytokine 
production
(38)
. 
 
Crude ethanolic extract of SA nuts was studied for its anti inflammatory 
activities in vitro using peripheral blood and synovial fluid mononuclear cells of 
healthy individuals and rheumatoid arthritis (RA) patients. 
 
 Semecarpus anacardium extract inhibited the spontaneous and LPS-induced 
production of pro inflammatory cytokines IL-1beta and IL-12p40 but had no effect on 
TNF-alpha and IL-6 production, both at protein and mRNA level. The crude extract 
also suppressed LPS-induced nuclear translocation of transcription factors, NF-kappa 
B and AP-1; the inhibition of NF-kappa B was through the inhibition of I kappa B α 
phosphorylation. The extract also suppressed LPS-activated nitric oxide production in 
mouse macrophage cell line, RAW 264.7
(39)
.  
 
 For immune modulatory potency, anti oxidative, membrane stabilizing, 
tumors marker regulative, glucose level restoring and mineral regulation properties of 
nut extract in hepato cellular carcinoma and found to detoxify a potent  Hepato  
carcinogen aflatoxin B1 and causes its metabolites to excreted in urine
(40)
.  
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In other case they explained the therapeutic effects of extract on the changes 
associated with collagen and  glycosaminoglycan  metabolism in adjuvant arthritic 
Wistar rats. Decreased levels of collagen and glycosaminoglycans (GAGS) 
components (chondroitin sulfate, heparan sulfate, hyaluronic acid) and increase in the 
levels of connective tissue degrading lysosomal  glycohydrolases such as acid 
phosphatase, beta-glucuronidase, beta-N-acetyl glucosaminidase and cathepsin-D 
observed in arthritic animals were reverted back to near normal levels upon treatment 
with SA. 
 
 The nut milk extract modulates reactive oxygen/nitrogen species levels and 
anti oxidative system in adjuvant arthritic rats. A significant increase in the levels of 
lipid peroxides (LPOs), ROS (superoxide radical, hydroxyl radical, H2O2 and 
myeloperoxidase) and RNS (nitrate + nitrite) observed in adjuvant arthritic animals 
were found to be significantly decreased on administration of the drug at 150 mg/kg 
body weight/day.  
 
Treatment with SA recouped the altered antioxidant defense components to 
near normal levels. These evidences suggest that the SA preparations are mainly used 
for irregularities caused during arthritis and to cure arthritis
(41)
. 
 
Kalpaamruthaa (KA), an indigenous-modified Siddha formulation, consists of 
SA nut milk extract and fresh dried powder of Emblica officinalis (EO) fruit along 
with honey. Kalpaamrutha was found to be nontoxic up to the dose level of 2000 
mg/kg. Further, KA has been reported for its potent antioxidant analgesic, antipyretic 
and non-ulcerogenic properties.   The  anti inflammatory activity of SA in adjuvant-
induced arthritic rat (AIA) model with reference to mediators of inflammation 
(lysosomal enzymes) and its effect on proteoglycans. The activities of various 
enzymes and levels of plasma protein bound carbohydrate components of 
glycoproteins were determined and were found to be elevated in arthritic rats when 
compared to control animals
(42)
. 
 
Antioxidant activity 
Semecarpus anacardium has been reported in various studies to possess potent 
antioxidant activity. The   antioxidant   activity of the aqueous extract of nuts of 
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medicinal plant SA in AKR mouse liver during development of lymphoma. 
Administration of the aqueous extract of SA to lymphoma-transplanted mouse leads 
to increase in the activities of antioxidant enzymes, whereas LDH activity is brought 
down significantly indicating a decrease in carcinogenesis
(43)
. 
    
The  antioxidant activity of ethyl acetate extract of stem bark of SA. Ethyl 
acetate extract showed the stronger antioxidant activity (due to presence of highest 
total phenolic content of 68.67% measured as pyrocatechol equivalent) compared to 
the other (hexane, chloroform and methanol) extracts.  
 
The isolation of the ethyl acetate extract of SA stem bark yielded a bright-
yellow solid crystal, which was identified as butein. This compound exhibited 
antioxidant activity (IC50 values of 43.28 ± 4.34 μg/ml), which was comparable to 
rutin, taken as a standard
(44)
. 
 
CNS activity 
The    beneficial effect of nuts of SA, extracted with milk, on CNS, mainly for 
its Locomotors   and nootropic  activities in different experimental animal models. 
The extract tested but a slight CNS depressant effect was noted with only 150 mg/kg 
of the extract and it was found to possess nootropic activity
(45)
. 
 
Antimicrobial activity 
The aqueous and organic solvent extracts of the plant and screened for 
antimicrobial (disc diffusion method) and phytochemical properties. The petroleum 
ether (PEE) and aqueous extract fractions (AQE) showed inhibitory activity 
against Staphylococcus aureus (10 mm) and Shigella flexneri (16 mm) at 100 mg/ml, 
respectively. While chloroform extract showed inhibition against Bacillus 
licheniformis, Vibrio cholerae and Pseudomonas aeruginosa, the ethanol extract 
showed inhibition to Pseudomonas aeruginosa and S. aureus
(46)
. 
 
The   alcoholic extract of dry nuts of SA (Bhallatak) showed bactericidal 
activity in vitro against three gram negative strains  (Escherichia coli, Salmonella 
typhi and Proteus vulgaris) and two gram positive strains (Staphylococcus 
aureus and Corynebacterium diphtheriae). Subsequent studies have shown that the 
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alcoholic extracts of different parts of the plant (leaves, twigs and green fruit) also 
possess anti-bacterial properties, especially the leaf extract.  No derma toxic effect 
(irritant property) was observed in the mouse skin irritant assay
(47)
. 
 
Hypoglycemic effect 
 The  effect of ethanolic extract of dried nuts of SA on blood glucose and 
investigated in both normal (hypoglycemic) and streptozotocin-induced diabetic 
(antihyperglycemic) rats. The ethanolic extract of SA (100 mg/kg) reduced the blond 
glucose of normal rats The blood glucose levels were measured at 0, 1, 2 and 3 h after 
the treatment and antihyperglycemic activity of SA was compared with tolbutamide, a 
sulfonyl urea derivative used in diabetes mellitus
(48)
. 
 
Kalpaamruthaa (KA), a modified Siddha preparation, which contains   
Semecarpus anacardium    studied for the variations in lipids, lipid-metabolizing 
enzymes and lipoproteins in cancerous animals and the effect of KA on the lipid 
metabolism. The increased levels of total cholesterol, free cholesterol, phospholipids, 
triglycerides and free fatty acids and decreased levels of ester cholesterol in plasma, 
liver and kidney found in cancer-suffering animals were reverted back to near normal 
levels on treatment with KA and SA. The effects of KA were found to be more 
effective than SA
(49)
. 
 
Anti-carcinogenic activity 
  Semecarpus  anacardium nut extract for inhibitory effect on human breast 
cancer cells (T47D). Cytotoxicity analyses suggested that these cells had become 
apoptotic. Semecarpus anacardium was discovered to induce rapid Ca(2+) 
mobilization from intracellular stores of T47D cell line, and its Cytotoxicity against  
T47D was well correlated with altered mitochondrial transmembrane potential. At the 
molecular level, these changes are accompanied by decrease in Bcl(2) and increase in 
Bax, cytochrome c, caspases and PARP cleavage, and ultimately by internucleosomal 
DNA fragmentation.  
 
Taken together, our results provide unprecedented evidence that SA triggers 
apoptotic signals in T47D cells
(50)
. 
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The  protective efficacy of preparation named as Kalpaamruthaa (KA) 
(includes SA nut milk extract, dried powder of  Phyllanthus  emblica  fruit and honey) 
on the peroxidative damage and abnormal antioxidant levels in the hepatic 
mitochondrial fraction of 7,12-dimethylbenz(a) anthracene  (DMBA)-induced 
mammary carcinoma rats. DMBA-treated rats also showed decline in the activities of 
mitochondrial enzymes. In contrast, rats treated with SA and KA showed normal lipid 
peroxidation antioxidant defenses in mitochondrial enzymes, and indicate the 
anticarcinogenic activity of KA during DMBA-initiated mammary carcinogenesis. On 
the basis of the observed results, KA can be considered as a readily accessible, 
promising and novel cancer chemopreventive agent
(51)
. 
 
Restoration  of energy metabolism in leukemic mice treated by SA nut milk 
extract. Leukemia-bearing mice showed a significant increase in LPOs, glycolytic 
enzymes, a decrease in gluconeogenic enzymes and significant decrease in the 
activities of TCA cycle and respiratory chain enzymes as compared to control 
animals. Semecarpus anacardium treatment was compared with standard drug 
imatinib mesylate.  Semecarpus anacardium administration to leukemic animals 
resulted in clearance of the leukemic cells from the bone marrow and internal 
organs
(52) 
 
Nephro toxicity: 
 The toxicity study on a few blood parameters in male albino rats at acute and 
sub-chronic levels with SA nut oil extract (50% w/v) in ground nut oil. Albino rats 
(Wistar strain) were treated orally with three sub-lethal doses. There was a significant 
decrease in hemoglobin percent and lowering of erythrocytes, indicating ‘anemia’ 
during toxicity study.  
 
He also evaluated the acute and sub-chronic effect of crude extract on activity 
of some kidney enzymes GOT, GPT, SDH, LDH and histology of kidney of albino rat 
(Wistar strain) in either sex. Significant alteration in activity levels of marker 
enzymes of kidney as well as histological structure leading to nephritis were 
observed, indicating renal dysfunctioning in albino rat. Results exhibited 
nephrotoxicity inducing potential of SA nut oil extract
(53)
.  
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                                      சிற்஫ாநணக்கு 
வயறு ப஧னர் : ஏபண்டம், சித்திபம், த஬வ஧ாடம் 
சுவய   :   வைப்பு 
தன்வந :  தட்஧ம் 
஧ிரிவு  :  ைார்ப்பு 
பசய்வை : 
 ஧ாற்ப஧ருக்ைி 
 யாதநடக்ைி 
 
                                        ஆநணக்பைண்பணய் 
குணம்:   
“வனபண்டத்துப஥ய் பனன்஧து டற்பைாடு 
     சீபண்டத்தணி பசய்திடு ஥ிசவந” 
- வதபன் ைாப்஧ினம் 
 
ப஧ாருள்:  
ஆநணக்கு எண்பணய், உண்வநனாை உடலுக்கு நிகுந்த ஥ன்வந 
பைாடுக்ைக் கூடினது. 
  “ஆநணக்கு ப஥ய்னால் ஥஬ப௃ண்டாம் னாயர்க்கும் 
  பூநைணக்கு வந஦ி புரிகுமவ஬-யாய்நணக்ை 
  பைாள்஭ில் யனிறுயிடுங் வைாபப௃ள்஭ யாயுயறும் 
  உள்஭ில்வ்ரு குன்நம்வ஧ா வநாது” 
- அைத்தினர் குண஧ாடம் 
சி஫ப்புப் ஧ண்பு: 
 இது நருந்தின் வயைம், ய஬ினி஦ால் எருயானிலுண்டாகும் அமவ஬ 
஥ீக்கும். 
 இவதப் வ஧தினாயதற்குக் பைாடுக்ை஬ாம். குமந்வதைளுக்கும் ஧ிள்வ஭ 
ப஧ற்஫ ப஧ண்ைளுக்கும் யனிறு ைமின பைாடுப்஧தற்கு இது சி஫ந்த நருந்தாகும். 
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                                      AAMANAKKU 
 
Botanical name: Ricinuscommunis 
Family  : Euphorbiaceae 
Suvai  : kaippu 
Thanmai : Veppam 
Pirivu  : Kaarppu 
Part used : Leaves, root and seed 
 
Chemical constituents: 
 Ricinine 
 N-Dimethylricinine 
 Asesquiterpenoid 
 Ricinoleic acid 
 Isoricinoleic acid 
 Dyhydroxy stearic acid 
 
Actions: 
 Anti-vatha 
 Immunomodulatory 
 Hepatoprotective activity 
 Anticancer activity 
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                                       ஧ன஦ வெல்஬ம் 
 
குணம்: 
  “ெட்டு ஧஦ வெல்஬த்தால் நார்வ஧ரிச்சல் குன்நநறும் 
  ப௃ட்டுந் திரிததாஷம் ப௃ன்஦஫ிகா – கட்டுநடா 
  ொந்தி ருசினின்னந ொ஭ா ப௅ற்஫ிடினும் 
  சாந்தி வ஧ருகுவநன்த஫ சாற்று.” 
 
஧ன஦வெல்஬த்தால் சுபசன்஦ி஧ாதம், திரிததாஷவதாந்தங்கள், 
அதபாசகம், குன்நம், நார்புஎரிச்சல், ஥ீங்கும். 
 
உ஧தனாகிக்கும் ப௃ன஫: 
 ஧ன஦ வெல்஬த்னத கனபத்து ெடிகட்டி ஧ாகு எடுத்துப் ஧ச்னச அரிசிநாவு 
கூட்டி அதிபசநாக சுட்டு உண்஧துண்டு. கா஧ி, தத஥ீர் இெற்஫ில் சாதாபணநாக 
அஸ்கா, பூபா ப௃த஬ினெற்஫ிற்கு ஧தி஬ாக இந்த ஧னணவெல்஬த்னதப் த஧ாட்டு 
சாப்஧ிடுெதுண்டு. இத஦ால் ததகத்தின் வெப்஧ம் அடங்கும். ஧ித்தம் த஦ிப௅ம். 
ததக ஆதபாக்கினம் உண்டாகும்.31 
 
தசரும் நருந்துகள்: 
 ஥ெபச வநழுகு 
 ஥ீபடிப௃த்து ெல்஬ாதி32 
 ப௄சாம்஧ப வநழுகு32 
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                                          Palm Jaggery 
 
 RESEARCH ARTICLES PUBLISHED IN JOURNALS:  
1. Jaggery from Palmyrah palm (Borassus flabellifer L.)- Present status 
and scope Vengaiah PC, Ravindrababu D2, Murthy GN3 & Prasad KR4 Horticultural 
Research Station, Pandirimamidi-533288, Andhra Pradesh, College of Agricultural 
Engineering, Bapatla-522101, Andhra Pradesh Jaggery is a sugar rich product and 
medicine obtained by evaporation of sugarcane (Saccharum officinarum L.) juice or 
sap obtained from Palmyrah palm (Borassus flabellifer L.), Date palm (Phoenix 
dactylifera L.) or Coconut palm (Cocos nucifera L.). Among all Jaggery, palm 
Jaggery having its own importance. It usually contains 65-85% sucrose and 5-15% 
reducing sugars, and is consumed directly or used for preparation of sweet 
confectionary items and ayurvedic/traditional medicines, and it may have a role to 
reduce the chance of lung cancer. It is a good source of minerals like calcium, 
phosphorous and iron. Jaggery industry is one of the most important cottage level 
industries in India since ancient times and it is prepared mostly by small and marginal 
farmers. Besides India, countries like Pakistan, Bangladesh, Nepal, Burma and 
Philippines are also manufacturing Jaggery.
54 
 
2. Physicochemical and thermal properties of candy crystals prepared 
from palmyra-palm jaggery LEELA CHAUHAN1,2, KUMAR SATYA 
PRAKASH3, P.P. SRIVASTAV1 and KHALID BASHIR  
Abstract  
Candy crystals prepared from palmyra palm were analyzed for various 
physical and chemical properties during processing. The scanning electron 
microscopy displayed smooth and clear crystals of varied sizes. As the temperature of 
the jaggery increased from 28C to 108.4C, there was a subsequent increase in the total 
soluble solids from 28.8 to 848Brix. Thermal conductivity decreased from 0.44 to 
0.14 W/mK, thermal diffusivity decreased from 0.31 3 1026 to 0.05 3 1026 m2/s and 
volumetric specific heat decreased from 1.35 3 103 to 0.64 3 103 kJ/m3_K. Thermal 
resistivity increased from 201.7 3 1022 to 755.1 3 1022 C_m/W. The maximum force 
taken as hardness was found to be 6,419 g. Power was found to be best for fitting the 
viscosity values (R250.93).
55 
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                                                               ஧சுந஥ய் 
 
குணம்: 
  “தாகமும ல஬சுட்கம் யாந்தி ஧ித்தம் யாம௃஧ிப 
  மநகம் யனிற்ந஫ரிவு யிக்க஬மல்-நாகாசங் 
  குண்நம் ய஫ட்சி குடற்புபட்ட ஬ஸ்திசட்கஞ் 
  நசான்மூ஬ம் ம஧ாக்கு஥ில஫த் துப்பு” 
ந஧ாருள்: 
 ஧சுயின் ந஥ய்னா஦து தாகம், உமல஬ப்஧ிணி, அதிசுட்கமபாகம், யாந்தி, 
஧ித்தாதிக்கம், யாதயிரம், யனிற்ந஫ரிவு, ஧ித்தயிக்கல், யனிற்றுய஬ி, 
குடல்ந஥஭ிதல், அஸ்திசூம்஧ல், மூ஬மபாகம் ஆகினயற்ல஫ ஥ீக்கும்.7 
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  4. MATERIALS AND METHODS 
 
Selection of the test drug: 
                          The test drug Rathi nagara rasa mezhugu was selected for the 
evaluation of toxicity studies in wister albino rats.  
 
Ingredients of Rathi nagara rasa mezhugu:-  
Sitramanakkennai (Castor oil)  - ¼ palam (8.75 gm) 
Gandhakam (Sulphur)              - 1 palam (35 gm) 
Serankottai (Semecarpus anacardium) - 30 Nos 
Vaalai rasam (Mercury)   - 1 palam (35 gm) 
Pasu nei (Ghee)    - 1 palam (35 gm) 
Panai vellam (Palm jaggery)  - 2 palam (35 gm) 
 
Procurement of the raw drugs: 
                  Rasam (Mercury), Ganthagam (Sulphur), Serankottai (Semecarpus 
anacardium) was procured from a reputed country shop, Broadway, Chennai. The 
following ingredients are Sitramanakku ennai (castor oil), Pasu nei (ghee), Panai 
vellam (palm jaggery) from procured from Tambaram market, Chennai . 
 
Identification and authentication of the raw drug: 
              The herbal drug were identified and authenticated by Botanist, NIS 
Tambaram sanatorium Chennai (Certificate no NISMB2942017). The metal drugs 
were identified by pharmacologist, dept. of Gunapadam, NIS, Tambaram sanatorium, 
Chennai. (Certificate no NIS/Gunapadam/Au2017/18). 
 
 The purification process: 
Purification of Rasam (Mercury):    
           35mg of Mercury triturated with brick powder and turmeric powder for one 
hour respectively, and washed with water. Then the mercury was boiled with 1 lit of 
the juice of Kuppai meni (Acalypha indica) until the juice evaporated completely. 
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 Purification of Gandhagam (Sulphur): 
              Sulphur was placed in an iron spoon. A small quantity of cow’s butter was 
added and the spoon was heated till the sulphur melts, then the melted sulphur 
immersed in the milk. This process was repeated for 21 times. 
 
 Purification of Serankottai:(Semecarpus anacardium): 
 Step 1: 
           The nose of the Serankottai should be chopped initially and put into the lime 
stone. 
 Step 2: 
            The Serankottai should be boiled with Puliyilai kudineer (Tamarindus indicus 
leaf extract) Purasampattai kudineer,(Butea monospermea), Pasum saanappaal (cow 
dung extract), Sottrukatralai (Aloe barbadensis) juices respectively and then wash 
with water dried. 
 
4.1 PREPARATION: 
Step 1: 
First castor oil is taken in a vessel and heated. Then Purified sulphur is 
powdered and mixed with the heating castor oil. When the sulphur melts, Semecarpus 
seeds are cut into two pieces and put in the oil. Then thailam is taken when 
semecarpus seeds turn red and floats. The thailam is called Rathi nagara thailam. 
Step 2: 
Mercury and Rathi nagara thailam is mixed and grinded. When mercury is 
grinded well, Ghee and palm jaggery is added and grinded to get Rathi nagara rasa 
mezhugu.  
 
THERAPEUTIC DOSAGE: 
3 to 4 kundri (490-520 mg), twice a day  
Duration of treatment is 3days 
VEHICLE: 
Palm jaggery 
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THERAPEUTIC USES: 
 Linga puttru (Penial cancer), 
 Algul puttru (Cervix cancer), 
 Araiyaappu (Adenitis), 
 Kandamaalai(Cervical adenitis),  
 Karunkuttam, Senkuttam (Leprosy),  
 Megaranam (Syphilis), 
 Kaalkai mudakku (Rheumatoid Arthritis). 
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Mercury After Purification 
Sulphur Before Purification Sulphur After Purification 
Serankottai Before Purification Serankottai After Purification 
Mercury Before Purification 
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  STANDARDIZATION OF RATHI NAGARA RASA MEZHUGU   
 
4.2 QUALITATIVE ANALYSIS  
PHYSICO-CHEMICAL ANALYSIS OF RATHI NAGARA RASA MEZHUGU 
(RNM): 
                       The physico- chemical properties of Rathi nagara rasa mezhugu is 
carried as per standard procedure at The Tamilnadu Dr. M.G.R. Medical University, 
Guindy, Chennai. 
 
1. Moisture Content:  
                   An accurately weighed 1g of Rathi nagara rasa mezhugu formulation was 
taken in a tarred glass bottle. The crude drug was heated at 105
0
 C in an oven till a 
constant weight. Percentage moisture content of the sample was calculated with 
reference to the shade dried material. 
 
 2. Determination of total ash:  
                        Weighed accurately 1g of Rathi nagara rasa mezhugu formulation was 
added in crucible at a temperature 600
0
 C in a muffle furnace till carbon free ash was 
obtained. It was calculated with reference to the air dried drug. 
 
  3. Determination of acid insoluble ash:  
                      Ash above obtained, was boiled for 5min with 25ml of 1M Hydrochloric 
acid and filtered using an ash less filter paper. Insoluble matter retained on filter paper 
was washed with hot water and filter paper was burnt to a constant weight in a muffler 
furnace. The percentage of acid insoluble as was calculated with reference to the air 
dried drug. 
 
 4. Determination of water soluble ash:  
                 Total ash 1g was boiled for 5min with 25ml water and insoluble matter 
collected on an ash less filter paper was washed with hot water and ignited for 15min 
at a temperature not exceeding 450
0
 C in a muffle furnace. Difference in weight of ash 
and weight of water.
57 
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 5. Determination of water soluble Extractive:  
                  1gm of air dried drug, coarsely powered Rathi nagara rasa mezhugu was 
macerated with 100ml of distilled water in a closed flask for twenty-four hours 
shaking frequently. Solution was filtered and 25 ml of filtrated was evaporated in a 
tarred flat bottom shallow dish, further dried at 1000 C and weighted. The percentage 
of water soluble extractive was calculated with reference to the air dried drugs. 
57 
 
 6. Determination of alcohol soluble extractive:  
                   1 gm. of air dried drugs, coarsely powdered Rathi nagara rasa mezhugu 
was macerated with 100 ml. alcohol in closed flask for 24 hrs. With frequent shaking. 
It was filtered rapidly taking precaution against loss of alcohol. 25ml of filtrate was 
then evaporated in a tarred flat bottom shallow dish, dried at 1000C and weighted. 
The percentage of alcohol soluble extractive was calculated with reference to air dried 
drug.
57 
 
THE PRELIMINARY PHYTOCHEMICAL SCREENING TEST: 
                         The preliminary phytochemical screening test was carried out for each 
extracts of Rathi nagara rasa mezhugu as per the standard procedure at The 
Tamilnadu DR. M.G.R. Medical University, Guindy, Chennai-32. 
 
Detection of alkaloids:  
Extracts were dissolved individually in diluted hydrochloric acid and filtered.  
 
Mayer's test: 
                 2 ml of extract was treated with few drops of Mayers’ reagent; formation of 
yellow coloured precipitate indicates the presence of alkaloids. 
 Wagner's test: 
                2 ml of filtrate was treated with Wagner's reagent. Formation of brown 
/reddish precipitate indicates the presence of alkaloids. 
  
Detection of carbohydrate:  
                      Extract was dissolved individually in 5 ml distilled water and filtered. 
The filtrates were used to test for presence of carbohydrates. 
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 Molisch’s test:    
                       2 ml of filtrate was treated with few drops of alcoholic Alpha naphthol 
solution in a test tube. Formation of the violet ring at the junction indicates presence 
of carbohydrates.  
 
Benedict’s test: 
                   Filtrate was treated with Benedict's reagent and heated gently. Orange red 
precipitate indicates the presence of reducing sugars.  
 
Detection of saponins: 
Froth test: 
                Extracts was diluted with distilled water to 20 ml and this was shaken in a 
graduated cylinder for 15 minutes. Formation of 1 centimeter layer of foam indicates 
the presence of Saponins.  
 
Foam test: 
                  0.5-gram extract was shaken with 2 ml of water. If foam produced persists 
for 10 minutes, it indicates the presence of saponins. 
 
 Detection of phytosterols 
 Salkowski's test: 
               Extracts was treated with chloroform and filtered; the filtrates were treated 
with few drops of concentrated sulphuric acid, shaken and allowed to stand for few 
minutes. Golden yellow colour indicates the presence of triterpenes.  
 
Detection of phenols 
 Ferric Chloride test:  
             2 ml of extracts was treated with 3-4 drops of ferric chloride solution. 
Formation of bluish black colour indicates the presence of phenols.  
 
Detection of tannins  
Gelatin test:  
               To the extracts, 1% of gelatin solution containing sodium chloride was 
added, formation of white precipitate indicates the presence of tannins. 
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 Detection of flavonoids 
 Alkaline reagent test  
             Extract was treated with few drops of 10% sodium hydroxide, formation of 
intense yellow colour then on addition of diluted hydrochloric acid it becomes 
colourless, it indicates the presents of flavonoids.  
 
Lead acetate test 
               Extract was treated with few drops of lead acetate solution, yellow colour 
precipitate indicates presence of flavonoids.  
 
Detection of diterpenes; 
 Copper Acetate test   
                 Extracts were dissolved in water and treated with 3-4 drops of copper 
Acetate solution, formation of emerald green colour indicates the presence of 
diterpenes. 
 
Test for gum and mucilage  
                    The extract was dissolved in 10 ml of distilled water and to this 2ml of 
absolute alcohol with the constant stirring white cloudy precipitate indicates the 
presence of gum and mucilage.  
Detection of Glycosides  
Liebermann's test 
                        2ml of extract was treated with 2ml chloroform and 2ml of acetic acid, 
Violet colour change into blue and green indicates presence of Glycosides.  
Test for Quinones 
                     Extract was treated with sodium hydroxide blue or red precipitate 
indicates the presence of Quinones. 
 
Result  
The Preliminary phytochemical studies of extract of Rathi naga rasa mezhugu 
in various solvents were done using standard procedures. The results were presented 
in tables. The present study reveals that the bioactive compounds were present in all 
the extracts of Rathi nagara rasa mezhugu. 
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BIO -CHEMICAL ANALYSIS OF RATHIRA NAGARASA 
MEZHUGU (RNM):  
 The bio–chemical analysis of Rathi nagara rasa mezhugu as done at 
Biochemistry lab, National Institute of Siddha, Chennai, 47 
Preparation of Extract:  
              5gm of Rathi nagara rasa mezhugu(RNM) is weighed accurately and placed 
in a 250ml clean beaker and added with 50ml of distilled water. Then it is boiled well 
for about 10 minutes. Then it is cooled and filtered in a 100ml volumetric flask and 
made up to 100ml with distilled water. This preparation is used for the qualitative 
analysis of acidic/ basic radicals and biochemical constituents in it. 
 
 
S.No EXPERIMENT OBSERVATION INFERENCE 
1.  Appearance of sample Dark brown in 
colour 
 
2. Test for Silicate: 
a. A little (500mg) of the sample is 
shaken well with distilled water. 
b. A little (500mg) of the sample is 
shaken well with con. HCl/Con. H2So4 
 
Sparingly soluble 
 
completely soluble 
Presence of 
Silicate 
3. Action of Heat: 
   A small amount (500mg) of the 
sample is taken in a dry test tube and 
heated gently at first and then strong. 
White fumes    
evolved 
 
Presence of 
Carbonate 
 
4. Flame Test: A small amount (500mg) 
of the sample is made into a paste with 
con. HCL in a watch glass and 
introduced into non-luminous part of 
the Bunsen flame. 
No bluish green 
flame appeared. 
Absence of 
Copper 
5. Ash Test: A filter paper is soaked into 
a mixture of sample and dil. cobalt 
nitrate solution and introduced into the 
Bunsen flame and ignited 
No yellow colour 
flame appeared 
Absence of 
sodium 
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Test for Acid Radicals 
S.No EXPERIMENT OBSERVATION INFERENCE 
1. Test For Sulphate: 
 2ml of the above prepared extract is 
taken in a test tube to this added 2ml 
of 4% dil ammonium oxalate solution 
No cloudy 
appearance present 
Absence 
of  Sulphate 
 Test For Chloride:  
2ml of the above prepared extracts is 
added with 2ml of dil-HCl is added 
until the effervescence ceases off... 
No cloudy 
appearance present 
Absence 
of Chloride 
3. Test For Phosphate: 
 2ml of the extract is treated with 2ml 
of dil.ammoniummolybdate solution 
and 2ml of con.HNO3 
No yellow 
precipitate present 
Absence 
of Phosphate 
4.  Test For Carbonate: 
2ml of the extract is treated with 2ml 
dil. magnesium sulphate solution 
cloudy appearance 
present 
Presence of 
carbonate 
5. Test For Nitrate: 
1gm of the substance is heated with 
copper turning and concentrated 
H2SO4 and viewed the test tube 
vertically down. 
 
No brown gas is 
evolved 
Abesence 
of Nitrate 
6. Test For Sulphide: 
1gm of the substance is treated with 
2ml of con. HCL 
No rotten Egg 
Smelling gas is 
evolved 
Absence 
of Sulphide 
7. Test For Fluoride & Oxalate: 
 2ml of extract is added with 2ml of 
dil. Acetic acid and 2ml dil.calcium 
chloride solution and heated. 
Absence of Cloudy 
appearance 
Absence 
of fluoride 
and oxalate 
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II.Test for Basic Radicals 
8. Test For Nitrite: 
3drops of the extract is placed on a 
filter paper, on that-2 drops of 
dil.acetic acid and 2 drops of 
dil.Benzidine solution is placed. 
No characteristic 
changes 
Absence 
of Nitrite 
9. Test For Borate: 
2 Pinches (50mg) of the substance is 
made into paste by using dil.sulphuric 
acid and alcohol (95%) and introduced 
into the blue flame. 
No bluish green 
colour flame 
appeared 
Absence 
of borate 
 
1. 
Test For Lead: 
 2ml of the extract is added with 2ml of 
dil.potassium iodine solution. 
 
No yellow 
Precipitate is 
obtained. 
Absence of 
Lead 
 
2. 
Test For Copper: 
One pinch (50mg) of substance is made 
into paste with con. HCl in a watch 
glass and introduced into the non-
luminous part of the flame. 
No blue colour 
precipitate is 
formed. 
 
Absence 
of copper 
 
3. Test For Aluminium: 
To the 2ml of extract dil.sodium 
hydroxide is added in 5 drops to excess. 
 
yellow colour 
appearance 
Presence of 
aluminum 
4. Test For Iron: 
A. To the 2ml of extract add 2ml of 
dil.ammonium solution 
B.  
b. To the 2ml of extract 2ml  thiocyanate 
solution and 2ml  of con HNo3 is added 
Mild red colour 
appear 
 
Blood red colour  
appearance 
 
Iron     
present 
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5. Test For Zinc:  
To 2ml of the extract dil.sodium 
hydroxide solution is added in 5 drops 
to excess and dil.ammonium chloride is 
added.  
 
white precipitate       
is   formed 
presence of 
Zinc 
6. Test For Calcium:  
2ml of the extract is added with 2ml of 
4% dil.ammonium oxalate solution  
 
Cloudy appearance 
or  white 
precipitate  
formation is 
present 
Presence 
of calcium 
7. Test For Magnesium:  
To 2ml of extract dil.sodium hydroxide 
solution is added in drops toexcess. 
 
white precipitate is  
obtained 
presence of 
Magnesium 
8. Test For Ammonium: 
To 2ml of extract 1 ml of Nessler's 
reagent and excess of dil.sodium 
hydroxide solution are added. 
 
 
No brown colour is 
appeared 
Absence 
of ammonium 
9. Test For Potassium: 
 A pinch (25mg) of substance is treated 
of with 2ml of dil.sodium nitrite 
solution and then treated with 2ml of 
dil.cobalt nitrate in 30% dil.glacial 
acetic acid. 
Yellowish 
precipitate is 
obtained. 
Presence 
of Potassium 
10. Test For Sodium: 
2 Pinches (50mg) of the substance is 
made into paste by using HCl and 
introduced into the blue flame of 
Bunsen burner. 
3  
No yellow colour 
flame appeared 
Absence 
of sodium 
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Test for other constituents 
11. Test For Mercury:  
2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution.  
 
  yellow precipitate 
is obtained 
 
presence 
of mercury 
12. Test For Arsenic:  
2ml of the extract is treated with 2ml of 
dil.sodium hydroxide solution. 
No brownish red 
precipitate is 
obtained 
 
Absence 
of arsenic 
1.  Test For Starch : 
2ml of extract is treated with weak 
dil.iodine solution  
 
No blue colour 
formation 
 
Absence of starch 
2.  Test For Reducing Sugar: 
5ml of Benedict's qualitative solution is 
taken in a test tube and allowed to boil for 
2 minutes and added 8 to 10 drops of the 
extract and again boil it for 2 minutes. The 
colour changes are noted. 
 
No brick red 
colour  
developed 
 
Absence of  reducing 
sugar 
3.  Test For The Alkaloids: 
a) 2ml of the extract is treated with   2ml of 
dil.potassium lodide solution. 
b)  2ml of the extract is treated with 2ml of 
dil.picric acid. 
reddish brown 
precipitation  
appears 
yellow 
precipitation 
appears 
 
 
Presence 
of Alkaloid 
 
 
4.  Test For Tannic Acid:  
2ml of extract is treated with 2ml of 
dil.ferric chloride solution 
 
No Black 
precipitate is 
obtained 
 
Absence of Tannic 
acid 
5.  Test For Unsaturated Compound: 
To the 2ml of extract 2ml of dil.Potassium 
permanganate solution is added.  
Potassium 
permanganate 
is not 
decolourised 
 
Absence 
of unsaturated 
compound 
6.  Test For Amino Acid: 
2 drops of the extract is placed on a filter 
paper and dried well. 20ml of Biurette 
reagent is added. 
 
Violet colour 
is  not 
developed 
 
Absence 
of amino acids 
7. Test For Type Of Compound: 
2ml of the extract is treated with 2 ml of 
dil.ferric chloride solution.  
No specific 
colour 
formation 
 
Phenols absent 
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4.3. QUANTITATIVE ANALYSIS 
 4.3.1 HEAVY METAL ANALYSIS  
                 The analysis of heavy metals and trace elements were estimated by using 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP- OES). The 
Experimental Procedure was done at SAIF, IIT Madras, Chennai-36.  
 ICP-OES:   
              Perkin Elmer Optima 5300DV was used for standard ICP-OES analysis. The 
optimized operating conditions are given in (table 5), the wavelength of analytical 
lines is given in table (5) and the test drug Rathi nagara rasa mezhugu underwent 
microwave digestion for sample preparation.   
Table 4.2.3 : ICP- OES Operating Conditions  
RF frequency 40M Hz 
Range 165-782 mm 
Detection limit Up to ppm level using SCD detector 
 
4.3.2 ANALYSIS OF PARTICAL SIZE   
         The particle size of the Rathi nagara rasa mezhugu was determined using High 
resolution scanning electron microscopy (HR SEM). The Experimental Procedure was 
done at SAIF, IIT Madras, Chennai-36.  
HR SEM:  
   The SEM analysis is carried out by using FEI-Quanta FEG 200-High Resolution 
Instrument.  
                  Resolution         :   1.2 nm gold particle separation on a carbon substrate  
                  Magnification   :   From a min of 12 X to greater than 1,00,000 X.  
 
Calculation of the particle size:  
The horizontal line in the right corner of the micrograph corresponds to micron in 
length would be given. A comparison could be made between the length of the 
particles visible in the micrograph with this line and the length of the particle was 
calculated.   
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4.4 TOXICITY STUDIES OF RATHI NAGARA RASA MEZHUGU 
 
To evaluate the Preclinical safety profile of Rathi nagara rasa mezhugu acute 
and sub acute toxicity study carried out as followed  
      
Principles of laboratory animal care were followed and the Institutional 
Animal Ethical Committee approved the use of animals and the study design. 
Institutional Animal Ethical Committee approval number: (IAEC). NIS/IAEC-
II/14/2016 for acute toxicity study and repeated dose 28-day oral toxicity study. 
 
1. ACUTE TOXICITY STUDY OF RATHI NAGARA RASA MEZHUGU
58
  
Experimental Animals:  
Species                              :          Wister Albino Rats 
 Sex                                        :          Female  
Age/weight                            :          6 weeks/140-160g b.wt  
Acclimatization Period       :          7 days prior to dosing  
Housing                                 :          Polypropylene cages with bedding with Husk  
Husbandry                            :      12-h light/12-h dark cycle/                                                               
                                                            Room temperature 22°C ± 3°C and    
                                                           Relative humidity 30–70%  
Feed and Water                  :           Rodent pelleted feed     
                                                            RO purified water ad libitum 
Identification  :         Animals will be kept in Polypropylene cages 
  and numbered                                   
 
Experimentation Details of Acute Toxicity Study:  
Groups/Treatment regimen                :  Grouped by randomization  
Test Guideline                                    :  OECD-423  
Length of exposure to test substance  : Once single dose 
 No of Animals                                    :  3 Female/ group 
 Control group                                     :  Vehicle (palm jaggery) 
 Test groups                                  :  Rathi nagara rasa mezhugu 50, 2000 
mg/kg.  b.wt                                                                             
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               The Female Albino Rats of weighing 150-200g were obtained from 
authorized animal breeders of the animal laboratory in TANUVAS, Madhavaram, and 
Chennai and stocked in the animal house at National Institute of Siddha, Chennai.  
Animals were housed in a cage at 22°C ±3°C and relative humidity 30–70% and have 
free access to standard rat pellet diet (Sai Meera Foods Pvt. Ltd., Bangalore). The 
animals were treated with Rathi nagara rasa mezhugu by oral route for one day and 
monitored for behavioral parameters for the first 4 hours (1/2 hr, 1hr,2 hr, 3 hr,4 hr) 
after drug administration. Body weight of the animal will be monitored at weekly 
intervals. All animals will be weighed and sacrificed under the injection of Pentothal 
Sodium on the 15th day of the Study period. The toxicological effect was assessed on 
the basis of mortality.  
 
Preparation of Test Drug Doses:  
Groups Dose No. of Rat 
Group I   Vehicle control (palm jaggery) 3 Female 
Group II 50 mg/kg b.wt 3 Female 
Group III  2000 mg/kg b.wt 3 Female 
 
Route of administration  
                        Oral route was selected because it is the normal route of clinical 
administration.  
 
Administration of Dose  
            The animals were fasted (only food was withheld) for 12hrs and weighed prior 
to dosing. Three animals were used for each step. A single dose of the solution (50, 
2000mg/kg) was consecutively administered by oral gavages using intubation 
cannula. The food was withheld for another 4hrs after dosing and administration of 
the drug. As per the guideline, the starting dose level was taken as 50mg/kg body 
weight. 
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Observations:  
 Observations were made and recorded systematically and continuously observed after 
the substance administration as per the guidelines.  
 ½ hour, 1 hour, 2 hours, 4 hours and up to 24 hours observation  
 All rats were observed twice daily for 14 days  
 Body weight  were Calculated weekly once  
 Feed & water intake  were Calculated daily 
Cage side observation: 
      The animals were monitored for behavioral parameters like Alertness, 
Aggressiveness, pilo erection, Grooming, Gripping, Touch Response, Motor Activity, 
Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, Hypnosis 
Analgesia, Lacrimation, Exophthalmos, Diarrhea, Writhing,  Respiration, Mortality  
Gross necropsy:  
                        At the end of the 14 th day, all the animals were sacrificed by using the 
injection of Pentothal sodium Gross necropsy includes examinations of the external 
surface of the body, all orifices, cranial, thoracic and abdominal cavities and their 
contents. Brain, lungs, heart, spleen, liver, kidneys, ovary and uterus of all animals 
also were grossly examined. 
2. REPEATED DOSE 28-DAY ORAL TOXICITY STUDY OF RATHI 
NAGARA RASA MEZHUGU
59 
Experimental Animals: 
 Species                                :     Wister Albino Rats 
 Sex                                       :      Male and Female  
Age/weight at start of test     :      6 weeks/140-160g b.wt 
 Acclimatization Period          :      7 days prior to dosing  
Housing                                  :      Polypropylene cages with bedding with Husk   
Husbandry                               :     12-h light/12-h dark cycle/                                                                  
                                                 Room temperature 22°C ± 3°C and                                                                  
                                                            Relative humidity 30–70%  
Feed and Water                      :     Rodent pelleted feed                       
                                                            RO purified water ad libitum  
Identification                           : Animals will be kept in Polypropylene cages  
and  numbered  
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Experimentation Details of Repeated dose 28 days Toxicity Study:  
Groups/Treatment regimen                 : Grouped by randomisation  
Test Guideline                                    :       OECD-407  
Length of exposure to test substance :        28 days  
No of Animals                                    :        3 Female+3 Male / group  
Control group                                     :        Vehicle (palm jaggery Solution)  
Test groups                                    :      Rathi nagara rasa mezhugu (Low dose,  
Mid dose, High dose) 
 
The 24 Wister albino rats of both sexes selected randomly. The animals were 
divided into four groups. Each group consists of 6 animals. The first group treated as 
vehicle control and second, third and fourth group were treated with Rathi nagara 
rasa mezhugu Low-dose (46.8mg), Mid dose (234mg), and High-dose (468 mg) 
respectively. The control animals were administered with palm jaggery as a vehicle. 
The other animals treated with Rathi nagara rasa mezhugu which was mixed with 
palm jaggery at the dose levels of low dose 46.8mg/ kg b.wt, Mid dose234 mg/kg 
b.wt and High dose 468 mg/kg b.wt. For 28 days. The administration was given by 
oral, once daily for 28 consecutive days. The animals were observed the behavioral 
parameters for the study period. Body weight of the animal was being monitored at 
weekly intervals. Food & water intake were Calculated daily. All the animals were 
sacrificed at the end of the study (29 days) by using the injection of Pentothal Sodium. 
Blood was collected from the anesthetized animals from the abdominal aorta for the 
following investigations like Hematology, Biochemical analysis. Gross pathological 
changes were monitored then the organs were studied by histo pathological 
examination.  
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The doses (Low, Mid, High dose) were fixed from the result from the acute 
toxicity study  
Group Dose No. of Rats 
Group I Vehicle control (palm jiggery) 6 (3M + 3F) 
GroupII Low dose ( RNM 46.8 mg/Kg b.wt) 6 (3M+ 3F) 
GroupIII Mid dose (RNM 234 mg/Kg b.wt) 6 (3M+ 3F)  
GroupIV High dose (RNM 468 mg/Kg b.wt) 6 (3M + 3F) 
  
Observations:  
Experimental animals were kept under observation throughout the course of study 
for the following  
 All rats were observed twice daily for 28 days  
 Body weight  were Calculated weekly once  
 Feed & water intake  were Calculated daily  
 
Cage side observation    
The animals were monitored for behavioral parameters like, Alertness, 
Aggressiveness, piloerection, Grooming, Gripping, Touch Response, Motor Activity, 
Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, Hypnosis 
Analgesia, Lacrimation, Exophthalmos, Diarrhea, Writhing,  Respiration, Mortality.  
  
Laboratory Investigations:  
       On the 29th day, the animals were fasted overnight, then anesthetized to 
collect blood samples from the abdominal aorta in two tubes:  one with  EDTA  for 
hematological parameters, another one without any anticoagulant and was centrifuged 
at 4000 rpm at 4°C for 10 minutes to obtain the serum for biochemical parameters.  
 
Hematological Investigations:  
         Blood samples of control and experimental rats were analyzed for hemoglobin 
(Hb), total red blood corpuscles  (RBC),  white blood corpuscles  (WBC) count, 
Platelet, Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), 
were calculated by auto analyzer.  
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Biochemical Investigations:  
             Serum samples of control and experimental animals were analyzed for, 
Bilirubin, BUN, Creatinine, Triglyceride, Total Cholesterol, HDL, LDL, VLDL, 
using standard methods. Activities of glutamate oxaloacetate transaminase/ Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine 
aminotransferase (GPT/ALT) were estimated as per the colorimetric procedure.   
 
Necropsy:  
           All the animals were sacrificed on the 29th day and Gross necropsy includes 
examinations of the external surface of the body, all orifices, cranial, thoracic and 
abdominal cavities and their contents. Brain, lungs, heart, spleen, liver, kidneys, 
testes, ovary and uterus of all animals also were grossly examined. 
Histopathology:  
            The organs included liver, kidneys, spleen, brain, heart, lungs, testes, ovary 
and uterus and stomach of the animals were preserved, and they were subjected to 
histopathological examination.  
Histopathological investigation of the vital organs was done. The organ pieces 
(35µm thick) of all the animals (low, mid, high) were preserved and fixed in 10% 
formalin for 24 hrs. Samples were dehydrated in an auto technic and then cleared in 
benzene to remove absolute alcohol.  Embedding was done by passing the cleared 
samples through three cups containing molten paraffin at 50
0
 C and then in a cubical 
block of paraffin made by the “L” molds. It was followed by microtome and the slides 
were Prepared then stained with Haematoxylin-eosin.  
 
Statistical analysis:  
            Findings   such   as body weight   changes,   food consumption,   water   
intake, and hematology and biochemical analysis were subjected to One-way 
ANOVA  Dunnet’s test using a computer software program followed by D Graph Pad 
Instat-3 
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                                                         RESULTS 
 
        After the preparation of the test drug Rathi nagara rasa mezhugu it undergone 
Biochemical, Physico chemical , ICP-OES, HR-SEM Analysis and Toxicity study and 
their results are given below. 
 
Results of Analytical studies on Rathi nagara rasa mezhugu: 
Table-1: Physico-chemical properties of Rathi nagara rasa mezhugu ( RNM) 
S.No                      Parameters                               Percentage 
 1  Loss on drying                                  1.98% 
 2 Total ash value                                   2.09% 
 3 Acid insoluble ash                            Less than 1% 
 4 Water insoluble ash                                   1.45% 
 5 Water soluble extraction                                   3.77% 
 6 Alcohol soluble extraction                                  15.59% 
 
 
Table: 2 Colour and nature of Rathi nagara rasa mezhugu ( RNM) 
S.no    Parameters      Results 
 1 Appearance Dark brown coloured semisolid  substance 
 2 PH at 25 c (1%w/v solution) 3.65 
 3 Solubility Partially soluble in water 
Partially soluble in acid 
Dispersed in alcohol 
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Table 3: Biochemical analysis of Rathi nagara rasa mezhugu 
S.NO                     PROCEDURES                      RESULTS 
    1                  Test for Ammonium                  -ve 
    2                     Test for Sodium -ve 
    3                 Test for Magnesium +ve 
    4                   Test for Aluminum +ve 
    5                  Test for Potassium +ve 
    6                 Test for Calcium +ve 
    7                 Test for Ferrous Iron +ve 
    8                  Test for Zinc +ve 
    9                  Test for Arsenic -ve 
   10                  Test for Mercury +ve 
   11                  Test for Lead -ve 
   12                  Test for Sulphate -ve 
   13                  Test for Chloride -ve 
   14                  Test for Phosphate -ve 
   15                  Test for Carbonate +ve 
   16            Test for Fluoride & Oxalate -ve 
   17                     Test for Starch -ve 
   18                 Test for Reducing sugar -ve 
   19                 Test for Alkaloids +ve 
   20                 Test for Amino Acids -ve 
   21     Test for Unsaturated compounds -ve 
 
(+) – present; (-) - Absent 
The biochemical analysis show the presence of carbonate, aluminum, iron, zinc, 
calcium, magnesium, potassium, mercury, alkaloid in Rathi nagara rasa mezhugu 
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Table 4: Phytochemical Analysis for Rathi nagara rasa mezhugu 
S.no         Phyto chemicals              Test name H 2O 
EXTRACT 
   1                Alkaloids            Mayer’s test -ve 
            Wagner’s test -ve 
   2          Carbohydrates             Molisch’ test  -ve 
            Benedict’s test -ve 
  3              Glycosides Libermann burchard’s test +ve 
  4              Saponins                 Froth test -ve 
                  Foam test -ve 
  5           Phytosterols            Salkowski’s test -ve 
  6              Phenols         Ferric choloride test -ve 
  7              Tannins              Gelatin test -ve 
  8             Flavonoids          Alkaline reagent test -ve 
            Lead acetate test  -ve 
  9   Proteins and amino acids           Xanthoproteic test -ve 
 10             Diterpenes          Copper acetate test  -ve 
 11        Fixed oil and fat                   Spot test +ve 
 12             Quinone             NAOH+ extract -ve 
  
The phytochemical analysis shows the presence of Glycosides and fixed oil and fat. 
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Table : 5  (ICP-OES) of Rathi nagara rasa mezhugu: 
S.no Elements 
Wavelength 
in  nm 
Rathi nagara rasa 
mezhugu mg/L 
1 Aluminium Al 396.152 BDL 
2 Arsenic As 188.979 BDL 
3 Calcium Ca 315.807 35.160 
4 Cadmium Cd 228.802 BDL 
5 Copper Cu 327.393 BDL 
6 Iron Fe238.204 10.243 
7 Sodium Na 589.592 14.890 
8 Zinc Zn 213.910 380.247 
9 Lead Pb 220.353 BDL 
10 Magnesium Mg  285.213 BDL 
11 Mercury Hg  253.652 03.214 
12 Potassium K 766.491 05.807 
13 Phosphorus P 213.617 126.321 
14 Nickel Ni 231.604 BDL 
 
 (ICP-OES) results showed that the Heavy metals like Aluminum, Arsenic, Copper, 
Lead, Magnesium, and Nickel  were found below detection level. Mercury (03.214 
mg/L) was found within the permissible level in RNM. It also shows the presence of 
physiologically important minerals like sodium, potassium, iron, zinc, Calcium, 
phosphorus. 
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Image :1  HR- SEM Analysis - Determination of particle size of  Rathi nagara 
rasa mezhugu: 
 
 
Results and Interpretation of SEM analysis: 
The morphology of the Rathi nagara rasa mezhugu (RNM) sample can be 
determined by SEM (FEI Quanta). We have observed from SEM photographs that 
particles are spherical in shapes and sizes are in the range from 0.5 micron to 2 
microns. Although the particle sizes of different batches showed similarity, it seems 
that these particles are aggregates of much smaller particles. When dispersed in an 
aqueous medium, these preparations form a negatively charged hydrophobic particle 
suspension. This hydrophobicity gives these particles a tendency to aggregate together 
to form larger particles. Rathi nagara rasa mezhugu exhibited larger sizes and 
agglomeration of the particles. Therefore, the comparatively larger size may be due to 
the agglomeration of the particles by repeated cycles of calcinations involved in 
preparation. 
 
 
 Preclinical safety evaluation of Rathi nagara rasa mezhugu  Page 70 
 
                                         ACUTE TOXICITY STUDY  
 
Table6. Behavioral Signs of Acute Toxicity Study of Rathi nagara rasa mezhugu 
(RNM)
 58 
No 
Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1 Control + - - + + + - - - - - - - - - - - - + - 
2 50 + - - + + + - - - - - - - - - - - - + - 
3 2000 + - - + + + - - - - - - - - - - - - + - 
 
1. Alertness 2.Aggressiveness 3.pilo erection 4.Grooming 5.Gripping 6.Touch 
Response 7. Motor Activity 8. Tremors 9.Convulsions 10.Muscle Spasm 11.Catatonia 
12. Muscle relaxant 13.Hypnosis 14.Analgesia 15.Lacrimation    16.Exophthalmos  
 17. Diarrhoea 18. Writhing 19. Respiration 20.Mortality   
+ Presence of Activity      - Absence of Activity 
 
All the data were summarized in the form of (table-6) revealed that there was 
no abnormal signs and behavioral changes in all animals at the dose level of 50, 2000 
mg/kg body weight administered orally, during the study period.   
There was no mortality observed after dosing of Rathi nagara rasa mezhugu 
(RNM) up to 2000mg/kg body weight during the study period of 14 days. This 
indicates that the LD50 of Rathi nagara rasa mezhugu is more than 2000mg/kg b.wt.  
There were no changes in skin and fur, eyes and mucous membranes of all 
animals.  The eating, drinking habit, sleep pattern, locomotion were normal in all 
animals and no changes in body weight as compared to control group.  
At the end of the 14 the day, necropsy was performed and there was no 
abnormality seen in test groups as compared to control group during the examination. 
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           28 Day Repeated Dose Oral Toxicity Study  
Food intake of the test group animals were observed and compared with 
control group during the study period. (Table 7), Food consumption of the animals is 
significantly differed but they are within physiological limit. 
Table: 7 Food (g/day) intakes of albino rats exposed to RNM 
Dose  
(mg/kg/ day) 
 
1
st
 day 
 
7
th
 day 
 
14
th
 day 
 
21
st
 day 
 
28
th
 day 
Control 12.45±0.16 13.15±0.16 12.95±0.21 12.8±0.21 13.15±0.16 
Low dose 12.8±0.21** 14.8±0.21** 16.95±0.38** 19.65±0.38** 21.3±0.32** 
Mid dose 12.45±0.54** 14.5±0.54** 16.8 ±0.54** 18.8±0.54** 19.95±0.71** 
High dose 13.15±0.16** 15.95±0.71** 18.15±1.25** 19.95±0.71** 21.65±0.71** 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
Figure 3: 
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   28 Day Repeated Dose Oral Toxicity Study   
Water intake of control and test group of animals observed during the study 
period. (Table 8), There was significant difference occurs in the group low and mid at 
28 days compared with control group. 
 
Table:8 Water (ml/day) intake of albino rats exposed to RNM 
Dose 
(mg/kg/day) 
 
1
st
 day 
 
7
th
 day 
 
14
th
 day 
 
21
st
 day 
 
28
th
 day 
Control 32.45±0.43 33.65±0.38 33.65±0.38 34.3±0.32 33.95±0.71 
Low dose 32.95±0.38* 32.95±0.38* 33.65±0.38 33.65±0.38* 32.95±0.38** 
Mid dose 34.15±0.93* 33.65±0.38 32.95±0.38* 33.65±0.38* 32.95±0.38** 
High dose 34.3±1.86 33.65±0.38 33.65±0.38 32.95±0.38 32.95±0.38 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
Figure 4: 
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28 Day Repeated Dose Oral Toxicity Study 
Body weight of both control and test dose group exhibited normal body weight 
throughout the study period. (Table 9) There was significant difference occurs in the 
group mid and high dose at 28 days compared with control group. 
Table: 9 Body weight (g) changes of albino rats (male) exposed to RNM 
Dose 
(mg/kg/day) 
 
1st day 
 
7th day 
 
14th day 
 
21st day 
 
28th day 
Control 178.66±19.03 197 ±27.87 214.66±29.73 249±37.51 266.66±4.52 
Low dose 199.66 ±9.07 215.33±5.50 229.66±10.59 256.3±6.35 283.33±15.27 
Mid dose 213.33 ±5.50** 224.33± 6.02* 247.66±12.09 276.66±7.63* 303.33±7.63* 
High  dose 230.33±21.59** 240 ±20** 254.66±22.81** 276.66±27.53 302.66±37.16* 
 
 Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
Figure 5: 
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                                       28 Day Repeated Dose Oral Toxicity Study   
Body weight of both control and test dose group exhibited normal body weight 
throughout the study period. (Table 10) There was significant difference occurs in all 
test groups  28 days compared with control group. 
Table: 10 Body weight (g) changes of albino rats (female) exposed to RNM 
Dose 
(mg/kg/day) 
 
1
st
 day 
 
7
th
 day 
 
14
th
 day 
 
21
st
 day 
 
28
th
 day 
Control 183.66±5.50 184.66±4.50 186.66±2.51 193.33±3.05 201.66±2.08 
Low dose 189.66±8.50 195±3* 201.66±6.65** 206.33±6.65** 209.33±6.65 
Mid dose 189.66±12.09 192±11.13 196.66±10.06* 207±2.64** 210.33±2.51 
High dose 196±7 200.66±5.03** 204.66±3.51** 212.66±6.42** 217.33±11.01** 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
 
Figure 6: 
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28 Day Repeated Dose Oral Toxicity Study 
The results of the Hematological investigations conducted at the end of the 
study, the groups revealed slightly significant changes in levels of hematological 
parameters, when compared with control group hematological parameters towards 
normal, when compared with control group. (Table 11) 
Table: 11 Effect of RNM on Hematological Parameters 
    Parameter       control             LD          MD          HD 
RBC (x10
6
µl) 6.68±0.40 7±0.35 6.03±0.52 6.13±0.72 
WBC(x10
3
µl) 8.3±2.02 7.53±1.92 9.58±1.27 9.08±3.32 
Platelets (x10
3
µl) 558.5±74.75 728.33±108.56 684.33±180.21 743±157.30 
HGB(g/dl) 11.61±1.50 14.41±2.08* 11.81±1.72 12.53±1.94 
Neutrophil 
(10
3
mm
3
) 
1.4±0.09 1.33±0.16 1.78±0.34 1.91±0.47* 
Lymphocyte (%) 88.48±3.96 69.3±1.44 69.05±4.21** 75.2±6.43** 
Monocyte(%) 4.41±0.72 3.78±1.53 3.3±0.51 4.53±0.30 
Eosinophil(%) 1.31±0.22 1.66±0.13** 1.08±0.16 1.25±0.16 
Basophil(%) 0.16±0.40 0.33±0.51 0.16±0.40 0.16±0.40. 
MCH(pg) 18.05±4.51 17.58±0.59 21.53±0.86* 22.06±0.90* 
MCV(fl) 58.28±3.30 58.86±5.24 58.35±4.21 55.55±4.75 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
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Figure 7: 
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5.4
5.6
5.8
6
6.2
6.4
6.6
6.8
7
RBC
R
B
C
 (
x1
0
6
µ
L)
Effect of RNM on RBC
Control
LD
MD
HD
0
2
4
6
8
10
Dose
W
B
C
 (
x1
0
3
µ
L)
Effect of RNM on WBC
Control
LD
MD
HD
 Preclinical safety evaluation of Rathi nagara rasa mezhugu  Page 77 
 
Figure 9: 
 
 
 
 
Figure 10: 
 
 
 
 
 
0
2
4
6
8
10
12
14
16
Dose
H
b
 in
 g
m
/d
L
Effect of RNM on Hb
Control
LD
MD
HD
0
100
200
300
400
500
600
700
800
Dose
P
la
te
le
ts
 (
x1
0
3
µ
L)
Effect of RNM on Platelets
Control
LD
MD
HD
 Preclinical safety evaluation of Rathi nagara rasa mezhugu  Page 78 
 
 
Figure 11: 
 
 
 
 
Figure 12: 
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28 Day Repeated Dose Oral Toxicity Study 
Biochemical investigations were conducted at the end of the study and the 
results were recorded. In test groups there was significant changes present in VLDL 
Mid dose, when compared with the control group. At the values were normal 
biological limits. (Table 12) 
Table12 Effect of Rathi nagara rasa mezhugu on Biochemical parameters  
Dose (mg/kg) control LD MD HD 
Total cholesterol 
(mg/dl) 
123.45±14.01 137.67±18.37 123.53±13.98 138.03±26.14 
HDL(mg/dl) 61.67±7.58 58.5±4.08 61.83±8.03 59±7.45 
LDL(mg/dl) 47.16±6.24 61.16±18.31 43.83±13.78 61.33±20.47 
VLDL(mg/dl) 12.05±0.95 15.56±1.40 20.35±5.34** 15.17±3.15 
Triglycerides(mg/dl) 39.16±14.06 37.16±8.28 42.83±10.72 38.66±9.09 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
Figure 13: 
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28 Day Repeated Dose Oral Toxicity Study 
The results of the renal functions test conducted at the end of study, test 
groups revealed no significant changes in levels of renal parameters, when compared 
with control group.(Table 13) 
Table13 effect of Rathi nagara rasa mezhugu on Renal parameters  
DOSE(mg/kg) control LD MD HD 
BUN(mg/dl) 13.5±1.87 12.5±3.39 11.83±1.94 13.5±2.88 
creatinine(mg/dl) 0.7±0.08 0.88±0.17 0.58±0.17 0.77±0.24 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
Figure 14: 
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  28 Day Repeated Dose Oral Toxicity Study 
The results of the liver function test conducted at the end of the study, test 
groups revealed no significant changes in levels of liver parameters, when compared 
with control group. 
Table14 Effect of Rathi nagara rasa mezhugu on Hepatic parameters  
Dose (mg/kg) Control LD MD HD 
Total 
bilirubin(mg/dl) 
0.41±0.07 0.65±0.49 0.4±0.17 0.67±0.33 
SGOT(U/L) 98.83±34.03 89±2.33 80.67±2.33 83.33±5.75 
SGPT(U/L) 28.16±4.44 23.83±3.71 39.66±4.08 25.66±4.32 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
 
 
Figure 15: 
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Figure 16: 
 
 
28 Day Repeated Dose Oral Toxicity Study 
The Organ weight no difference in organ weight of control and test group 
observed after 28th days repeated oral toxicity study period, and satellite group was 
sacrificed after 14 days of drug withdrawal.(Table 15) 
Table: 15 Organ Weight (g) Changes of Wister albino Rats Exposed to Rathi 
nagara rasa mezhugu 
Organs Control LD MD HD 
Heart 0.45±0.02 0.52±0.10 0.61±0.11 0.60±0.01 
Lungs 1.13±0.21 1.3±0.34 1.4±0.02 1.62±0.51 
Liver 7.24±1.77 7.12±1.12 6.98±0.11 7.12±1.65 
Rt.kidney 0.73±0.07 0.78±0.41 0.74±0.43 0.75±0.20 
Lt.kidney 0.79±0.09 0.78±0.07 0.75±0.01 0.73±0.19 
Spleen 0.47±0.21 0.44±0.08 0.45±0.02 0.53±0.13 
Brain 1.41±0.12 1.55±0.08 1.46±0.02 1.63±0.09 
Stomach 1.26±0.16 1.41±0.09 1.32±0.16 1.38±0.18 
 
Values were expressed as mean± S.D. for N=6 rats in each group one-way ANOVA 
followed by Dunnett’s test. Significant indicates that *P<0.05,**P<0.01 
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Figure 17: 
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28 Day Repeated Dose Oral Toxicity Study   
HISTOPATHOLGY OF BRAIN 
 
   
Plate A:Control Male               Plate B: Control Female 
   
Plate C : High dose Male       Plate D: High dose Female 
 
Plate A: No signs of ischemic changes in the cerebral hemisphere of the brain sample 
Plate B: Normal arrangement of neurons with proper inter neuronal space were 
observed in cerebrum  
Plate C: Arrangement of neurons on cerebral cortex appears normal and dense. No 
signs of degeneration and other abnormalities 
Plate D: The cerebral sections showed normal architecture in both cortex and medulla 
without any changes 
Preclinical safety evaluation of Rathi nagara rasa mezhugu Page 85 
 
28 Day Repeated Dose Oral Toxicity Study   
HISTOPATHOLGY OF HEART 
 
                                       
Plate A: Control Male                                       Plate B: Control Female                         
    
        
 Plate C: High dose Male                   Plate D: High dose Female 
 
Plate A: Sarcoplasmic region of myocardium appears normal 
Plate B:  Sarcoplasmic region of myocardium appears normal 
Plate C: Myocardial cells appears normal with well-defined mycoplasma and 
prominent nucleus and nucleolus. 
Plate D: Fibres appears normal elongated and rod shaped 
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28 Day Repeated Dose Oral Toxicity Study   
HISTOPATHOLGY OF LUNGS 
 
           
Plate A:Control Male                            Plate B: Control Female 
          
Plate C : High dose Male                   Plate D: High dose Female 
 
Plate A: Arrangement of epithelial and muscular appears normal 
Plate B: Lung parenchyma appears normal with regular arrangement of alveoli 
Plate C: Bronchial blood vessels and connective tissue appears normal with no sings 
of pulmonary edema 
Plate D: No signs of airway secretion and bronchial secretion 
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28 Day Repeated Dose Oral Toxicity Study   
HISTOPATHOLGY OF LIVER  
 
      
Plate A:Control Male       Plate B: Control Female 
 
                
Plate C : High dose Male       Plate D: High dose Female 
 
Plate A: Section of liver showing normal, homogenous, intact hepatic parenchyma. 
Plate B: liver showing normal hexagonal hepatic lobules with normal, regular 
radiated hepatic cords 
Plate C: The centrilobular hepatocytes appears normal with stained cytoplasm. 
Plate D: Liver parenchyma appears normal with no evidence of necrosis 
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28 Day Repeated Dose Oral Toxicity Study   
          HISTOPATHOLGY OF STOMACH 
 
           
Plate A:Control Male      Plate B: Control Female 
`   
Plate C : High dose Male    Plate D: High dose Female 
 
Plate A: Appearance of Sub-mucosa and gastric glands appear normal 
Plate B: No signs of ulcer and glandular degeneration were observed 
Plate C: Gastric glands, gastric glands including secretary sheath appears normal. 
Plate D: Mucosal wall appears normal with regular arrangement of connective tissue 
 
Preclinical safety evaluation of Rathi nagara rasa mezhugu Page 89 
 
28 Day Repeated Dose Oral Toxicity Study   
    HISTOPATHOLGY OF  KIDNEY 
 
   
Plate A:Control Male    Plate B: Control Female 
   
Plate C : High dose Male    Plate D: High dose Female 
 
Plate A: Glomerular Basement Membrane (GBM) separating between Capillary 
Space (Cs) and Urinary Space (Us) was normal. 
Plate B: Appearance of proximal and distal convolutes tubules was normal with no 
evidence of atrophy 
Plate C: Some renal tubules are hypertrophic, others are dilated. 
Plate D: Basement membrane of the capillaries are thickened .Some renal tubules are 
hypertrophic 
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28 Day Repeated Dose Oral Toxicity Study   
       HISTOPATHOLGY OF SPLEEN 
 
   
Plate A:Control Male    Plate B: Control Female 
   
Plate C : High dose Male    Plate D: High dose Female 
 
Plate A: Appearance of splenic sinuses, Splenic cord and endothelial orientation was 
normal. 
Plate B: Erythropoietic cells (EP) are scattered throughout the red pulp of both the 
samples. No abnormalities found in lymph node of both the samples 
Plate C: Presence of marginal at the interface of the red pulp with the PALS and 
follicles was observed. 
Plate D: Marginal vascular zone radiated in between red and white pulp 
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28 Day Repeated Dose Oral Toxicity Study   
    HISTOPATHOLGY OF TESTES 
  
 
     Plate A:Control Male 
       
       Plate B : High dose Male  
 
Plate A: Normal sertoli cell aligned properly on the basement membrane with oval 
dome shaped nucleus 
Plate B: Sperm oriented towards the center of sertoli cells with cluster of tail 
projected outside was observed 
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28 Day Repeated Dose Oral Toxicity Study   
     HISTOPATHOLGY OF UTERUS 
 
       
      Plate A: Control Female 
 
      
       Plate B : High dose Female 
  
Plate A: Appearance of endometrium, myometrium and uterine glands was normal 
Plate B : Endometrial stroma; G, gland; M, myometrium; P, perimetrium; L, lumen 
exhibits normal histological aspect of endometrium and myometrium. 
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28 Day Repeated Dose Oral Toxicity Study   
     HISTOPATHOLGY OF UTERUS 
 
 
Plate A:Control Female 
 
 
Plate B : High dose Female  
 
Plate A: Follicular cells, cytoplasm and nucleus appears normal 
Plate B : Histopathological analysis of ovary showing normal corpus luteum (CL) and 
Primordial follicles with few mature ovarian follicles with no signs of abnormality 
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                                                6. DISCUSSION 
 
       I have selected Rathi nagara rasa Mezhugu (RNM) to evaluate the safety 
profile. First the test drug going to the process of standardization for qualitative and 
quantitative analysis. The following analysis are: 
 Physico - chemical analysis  
 Bio-Chemical Analysis  
 ICP-OES 
 SEM Analysis 
 The safety profile is evaluated by Acute and sub acute toxicity study on Wister 
Albino rats as OECD 423& 407 guideline. 
 
The Physico - chemical analysis of RNM (Table: 1&2) concludes the following 
results  
The loss on drying test is designed to measure the amount of water and 
volatile matters in a sample when the sample is dried under specified conditions. 
Moisture is one of the major factors responsible for the determination of the drugs and 
formulations. Low moisture content is always desirable for higher stability of drugs. 
The percentage of loss on drying of RNM was 1.98% (Normal range: 1-20%). Since 
the loss of drying of RNM is low, the stability of the drug is higher.  
 
The Ash limit Tests are designed to measure the amount of the residual. A 
high ash value is indicative of contamination, substitution, adulteration or carelessness 
in preparing the drug. The total ash values of RNM were 2.09% (Normal range: 1-
25%). Since the value of total ash in RNM is low, it implies that the inorganic 
constituents is Low this indicates the purity of the drug.  
 
The Acid-Insoluble Ash limit Test is designed to measure the amount of ash 
Insoluble to diluted hydrochloric acid. Acid-insoluble ash value of RNM is 0.7% 
(Normal range: 0.1 – 10%) and it shows that a very small amount of the inorganic 
Constituent is insoluble in acid. It indicates the purity of the drug.  
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Extraction value determines the amount of active constituents in a given 
amount of the formulation when extracted with a solvent media such as water and 
alcohol. The water soluble and alcohol soluble extract values provide an indication of 
the extent of polar and non polar compounds respectively present in RNM. The 
extract values of Alcohol in RNM is 15.59% (Normal range:4-85%) and water is 
3.77%(Normal range:485%). From the above result we conclude that water is a little 
better solvent of extraction than alcohol.  
 
pH of the drug was 4.65 (Normal value:4-14). It denotes it is slightly acidic. 
Hence, in the oral administration of the drug it is expected to be absorbed quickly in 
the stomach. It reveals that RNM is expected to have better Bio-availability. 
 
Bio Chemical Analysis of Rathi nagara rasa mezhugu indicated the presence 
of carbonate, calcium, magnesium, potassium, aluminum, iron, zinc, mercury, and 
alkaloid. 
 
Phytochemical investigation to detect the presence of phyto constituents in 
formulation RNM reveals the presence of glycosides and fixed oil and fat. 
 
The Inductively Coupled Plasma Optical Emission Spectrometry (ICP-
OES) of Rathi nagara rasa mezhugu results showed that the Heavy metals like 
Aluminum, Arsenic, Copper, Lead, Magnesium, and Nickel  were found below 
detection level. Mercury (03.214 mg/L) was found within the permissible level in 
RNM. Hence it may be safe for human consumption. It also shows the presence of 
physiologically important minerals like sodium, potassium, iron, zinc, Calcium, 
phosphorus (Table.5). 
 
  High Resonance Scanning Electron Microscopy (HR-SEM) analysis of 
Rathi nagara rasa mezhugu showed difference in size and reveals the particle size as 
0.5 – 2 micron which is considerably less due to repeated calcinations and grinding. 
Hence the drug may have increased absorption. The particles in RNM had uneven 
distribution with agglomeration of particles. Agglomeration of the particles is due to 
repeated cycles of calcinations involved in preparation (Image.1). 
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Acute Toxicity Study was done as per OECD Guideline-423 with dose levels 
of 50, 2000 mg/kg b.wt. Throughout the 14 days of observation period, no mortality 
was observed in Rathi nagara rasa mezhugu treated groups. No abnormal behavioral 
signs were observed in treated groups. Further, no gross pathological changes have 
been seen in the internal organs of both control and treated groups. Since there was no 
mortality in dose of 2000mg/kg.wt, the LD50 cut off value falls on above 2000mg/kg 
b.wt. So the drug Rathi nagara rasa mezhugu comes under the Category-5 according 
to GHS (Globally Harmonized System for the Classification of chemicals)
 60
 as per 
the OECD guideline-423 and this provides direct relevance for protecting human and 
animal health.  
 
Repeated Oral Toxicity Study was conducted for 28 days as per the OECD 
guideline-407. All animals from control and all the treated dose groups survived 
throughout the dosing period of 28 days. There was no mortality, morbidity and 
behavioral changes during cage side observation. Food and water consumption of the 
animals is significantly differed When RNM treated drugs compare to control group 
(Table7,8& Figure2,3). But they are within physiological limit, and this study reveals 
that it does not adversely affect the basic metabolic processes of the experimental 
animals. 
 
On 29
th
 day all animals are sacrificed and blood was collected.  After blood 
collection, all the animals were euthanized for gross pathological examinations of all 
major internal organs. The blood samples were sent to a lab for hematological and 
biochemical analysis.  The organs were weighed and preserved in 10% buffered 
formalin solution before sending for histopathological study. All the reports were 
statistically analyzed.  
 
The results of hematological investigation, reveals no significant changes in 
all Rathi nagara rasa mezhugu treated groups as compared with the control groups 
except for total differential count, hematocrit but the values are within the normal 
physiological limit.  
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The results of biochemical investigations, in test groups there was significant 
changes present in VLDL Mid dose, when compared with the control group. But the 
values were normal biological limits. 
 
The result of liver function test and renal function test, reveals no significant 
changes in all RNM treated groups as compared with the control groups. 
           
   Relative organ weights of treated animals when compared with respective 
control animals did not reveal any abnormalities..  
 
The histopathological study, the vital organs such as brain, heart, liver, spleen, 
kidneys, lungs, testes and ovary were removed from the test groups at the end of the 
study and carefully observed macroscopically to find any observable gross lesions 
compared with the control group and did not reveal any abnormal macroscopic 
changes. Histopathology of vital organ revealed normal histological appearance when 
compared with the control. 
 
 
 
 
.  
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7. SUMMARY 
 
Preclinical safety evaluation of Rathi nagara rasa mezhugu (RNM) was carried 
out for dissertation. The drug was chosen from the Siddha literature Anuboga vaidhaya 
navaneedham. The ingredients of Rathi nagara rasa mezhugu are metallic and herbal 
compounds like Rasam (Mercury), Ganthagam (Sulphur), Serankottai (Semecarpus 
anacardium). It cures the disease of Lingaputtru (penial cancer), Algulputtru (Cervix 
cancer), Araiyaappu (Adenitis), Kandamaalai (Cervical adenitis), Karunkuttam, Senkuttam 
(Leprosy), Megaranam (Syphilis), Kaalkai mudakku (Rheumatoid Arthritis). 
6 
 
The raw drugs were procured from reputed raw drug shop, Broadway, Chennai and 
the drugs were identified and authenticated by dept. of Gunapadam, and by the Botanist, 
National Institute of Siddha, Chennai. The ingredients were purified and the medicine was 
prepared as mentioned in the Siddha literature. Rathi nagara rasa mezhugu was underwent 
physicochemical, phyto- chemical, biochemical analysis, heavy metal analysis by using 
ICP-OES, and particle size analysis by using HR-SEM. Acute and Repeated oral 28 day 
toxicity were conducted as per the OECD guidelines 423 & 407 respectively
58,59
. 
  
In Rathi nagara rasa mezhugu, the loss on drying at 105
o
C was found to be 1.98%, 
it falls in between the limit range (1-20%). So the determination of moisture content shows 
the good stability of the drug test drug. The total ash in the test drug was found to be 
2.09%, and the acid insoluble ash to be 0.7%. Both types of ash values were within the 
limits. The minimal level of acid insoluble ash shows the less extraneous matters that 
indicate the purity of the drug RNM. 
 
 The water soluble extract value of Rathi nagara rasa mezhugu is 3.77% and the 
Alcohol soluble extractive is 15.59%.As the test drug has more alcohol soluble 
constituents than water soluble, it would be non-polar. So the drug will have good 
bioavailability &intracellular distribution without possible accumulation inside the cells. 
The poor water solubility may prolong the duration of the drug action.  
 
The pH of RNM was found to be 4.65 which means it is weekly acidic and safe for 
oral administration. 
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Bio Chemical Analysis of RNM indicated the presence of carbonate, calcium, 
magnesium, potassium, aluminum, iron, zinc, mercury, and alkaloid. 
 
Phytochemical investigation to detect the presence of phyto constituents in 
formulation RNM reveals the presence of glycosides and fixed oil and fat.  
 
The Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) 
of RNM results showed that the Heavy metals like Mercury (03.214 mg/L) was found 
within the permissible level in RNM. Hence it may be safe for human consumption. It also 
shows the presence of physiologically important minerals like sodium, potassium, iron, 
zinc, Calcium, phosphorus. Some Heavy metals shows below detection level are 
Aluminum, Arsenic, Copper, Lead, Magnesium, and Nickel (Table.5). 
 
HR-SEM analysis of Rathi nagara rasa mezhugu showed difference in size and 
reveals the particle size as 1.0 - 2.0 µ. The particles in RNM had even distribution with 
agglomeration of particles due to reported grinding. Hence the drug may have increased 
absorption. 
 
 In Acute Oral Toxicity study four different dose (50, 2000mg /kg.b.wt) of Rathi 
nagara rasa mezhugu were administered stepwise (step up) manner.  Throughout the  
14 days of observation period, no mortality and signs of toxicity were observed in RNM 
treated groups. The results of the Acute Oral Toxicity study indicate that the LD50 of 
RNM is more than 2000 mg/kg b.wt. So the drug RNM comes under the category 5 as per 
GHS (Globally Harmonized System of Classification).
60 
 
In the 28-days repeated dose oral toxicity study, there were no mortality and 
morbidity in all Rathi nagara rasa mezhugu treated groups.  
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Food and water consumption of the animals is significantly differed When RNM 
treated drugs compare to control group(Table7,8& Figure2,3). But they are within 
physiological limit, and this study reveals that it does not adversely affect the basic 
metabolic processes of the experimental animals. 
 
Body weight of the animals is significantly differed When RNM treated drugs 
compare to control group (Table9,10 & Figure4,5). But they are within physiological 
limit. 
 
The results of hematological investigation, reveals no significant changes in all 
RNM treated groups as compared with the control groups except for total differential 
count, hematocrit but the values are within the normal physiological limit.  
 
The results of biochemical investigations, in test groups there was significant 
changes present in VLDL Mid dose, when compared with the control group. But the 
values were normal biological limits. 
 
The result of liver function test and renal function test, reveals no significant 
changes in all RNM treated groups as compared with the control groups. 
          
No abnormality was observed in histopathological examinations of all organs in 
RNM treated groups as compared with the control groups. 
 
 So the ‘No Observed Adverse Effect Level’ (NOAEL) of Rathi nagara rasa 
mezhugu may be greater than 468 mg/kg b.wt in Repeated Oral 28-day Toxicity study. 
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8. CONCLUSION 
From the results of this analytical evaluation of the test drug Rathi nagara rasa 
mezhugu (RNM), it is inferred that quality and stability was good when prepared under the 
standard protocol mentioned in this study. Qualitative analysis of RNM reveals the Purity 
and Bioavailability of the drug As heavy metals were found to be within the permissible 
limit .so the drug is safe for oral consumption. The particulate size of the test drug was 
determined by SEM analysis. In vivo toxicity study reveals the drug RNM shows no 
mortality and signs of toxicity up to 2000 mg/kg.b.wt in acute oral administration.             
In Sub acute toxicity study there was significantly changes in hematological, biochemical 
parameter in RNM treated groups when compared to control group but the levels were 
within physiological limit.  The histopathology report also confirms that there are no 
remarkable cellular changes at all the dose levels. And No Observed Adverse Effect Level 
(NOAEL) high dose level (468 mg/kg b.wt), which is ten times that of therapeutic dose.. 
Based on these results it can be conclude that, the dose level of Rathi nagara rasa mezhugu 
3 to 4 kundri twice a day mentioned in the Siddha literature Anoboga vaithya 
navaneetham 
6 
is safe dosage for human consumption.  
In future it is to be carried out to study the pharmacological activity and clinical 
trial to prove the efficacy of the drug.  
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10. ANNEXURE 
 
The following certificates are enclosed 
1. Research Methodology and Biostatistics  
2. IAEC Certificate for acute and sub acute toxicity study. 
3. Authentication certificate for herbal plants. 
4. Authentication certificate for metal drugs. 




